1
|
Al-Saleh I, Elkhatib R, Alghamdi R, Alrushud N, Alnuwaysir H, Alnemer M, Aldhalaan H, Shoukri M. Phthalate exposure during pregnancy and its association with thyroid hormones: A prospective cohort study. Int J Hyg Environ Health 2024; 261:114421. [PMID: 39002474 DOI: 10.1016/j.ijheh.2024.114421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Revised: 06/30/2024] [Accepted: 07/02/2024] [Indexed: 07/15/2024]
Abstract
Phthalate esters (PAEs) possess endocrine-disrupting properties. Studies in humans have indicated that in utero phthalate exposure affects maternal thyroid hormones, which are essential for fetal growth and development. However, these studies also reported inconsistent results on the relationship between phthalates and thyroid hormones. This prospective cohort study aimed to assess phthalate exposure across the three trimesters of pregnancy and its association with thyroid hormone levels. From 2019 to 2022, we recruited 672 pregnant women, and two urine samples and one blood sample were collected from each participant during the pregnancy. We examined the urine samples from 663, 335, and 294 women in the first, second, and third trimester, respectively, for the following seven phthalate metabolites: monoethyl phthalate (MEP) from diethyl phthalate (DEP); mono-n-butyl phthalate (MnBP) and mono-iso-butyl phthalate (MiBP) from dibutyl phthalate (DBP); monobenzyl phthalate (MBzP) from butyl benzyl phthalate; and three di(2-ethylhexyl) phthalate (DEHP) metabolites, mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP). Additionally, we examined the levels of free thyroxine (FT4), thyroid-stimulating hormone (TSH), and total triiodothyronine (TT3) in the serum samples of the following participants: 596, 627, and 576 in the first trimester; 292, 293, and 282 in the second trimester; and 250, 250, and 248 in the third trimester, respectively. Other than MBzP, which was detected in 25%-33% of the samples, other metabolites were detectable in >86% of urine samples, indicating widespread exposure to DEP, DBP, and DEHP. The detected phthalate exposure levels in our cohort were significantly higher than those reported in other countries. Metabolite levels varied across the trimesters, implying changes in exposure and metabolism throughout pregnancy. The observed variability in urinary concentrations of phthalate metabolites, which ranged from poor to moderate, underscores the importance of taking multiple measurements during pregnancy for precise exposure assessment. Using a linear mixed model, we analyzed the effects of repeated phthalate exposure on thyroid hormone levels while adjusting for potential confounders. We observed significant linear trends in FT4, TSH, and, to a lesser extent, TT3 across quartiles of specific phthalate metabolites. Comparing the highest to the lowest quartiles, we found a significant increase in FT4 levels, ranging from 2 to 3.7%, associated with MEP; MECPP; MEHHP; and the sum of seven metabolites (∑7PAE), three DEHP metabolites (∑3DEHP), two DBP metabolites (∑DBP), and both low molecular weight (∑LMW) and high molecular weight metabolites. Increased TSH levels (5%-16%) were observed for all phthalate metabolites (except MEHHP) and their molar sums, including ∑7PAE. For TT3, a significant increase was observed with MEP (2.2%) and a decrease was observed with ∑DBP (-2.7%). A higher TSH/FT4 ratio was observed with the highest quartiles (third or fourth) of several phthalate metabolites: MEP (8.8%), MiBP (8.7%), MnBP (22.2%), ∑7PAE (15.3%), ∑DBP (16.4%), and ∑LMW (18.6%). These hormonal alterations, most notably in the second and third trimesters, suggest that phthalate exposure may impact fetal growth and development by affecting maternal thyroid function.
Collapse
Affiliation(s)
- Iman Al-Saleh
- Environmental Health Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
| | - Rola Elkhatib
- Environmental Health Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Reem Alghamdi
- Environmental Health Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Nujud Alrushud
- Environmental Health Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Hissah Alnuwaysir
- Environmental Health Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Maha Alnemer
- Obstetrics and Gynecology Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Hesham Aldhalaan
- Center for Autism Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Mohamed Shoukri
- Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
| |
Collapse
|
2
|
Jeon H, Yeo S, Park EA, Kang D, Shen K, Kim M, Lee I, Jeon J, Moon B, Ji K, Kim S, Kho Y. Identification and quantification of acetyl tributyl citrate (ATBC) metabolites using human liver microsomes and human urine. CHEMOSPHERE 2024; 363:142840. [PMID: 39019193 DOI: 10.1016/j.chemosphere.2024.142840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Revised: 07/08/2024] [Accepted: 07/11/2024] [Indexed: 07/19/2024]
Abstract
Plasticizers are chemicals that make plastics flexible, and phthalates are commonly used. Due to the toxic effects of phthalates, there is increasing use of non-phthalate plasticizers like acetyl tributyl citrate (ATBC). ATBC has emerged as a safer alternative, yet concerns about its long-term safety persist due to its high leachability and potential endocrine-disrupting effects. This study aims to identify ATBC metabolites using human liver microsomes and suspect screening methods, and to explore potential urinary biomarkers for ATBC exposure. Using ultra-high-performance liquid chromatography coupled with high-resolution mass spectrometry, we identified ATBC metabolites, including acetyl dibutyl citrate (ADBC), tributyl citrate (TBC), and dibutyl citrate (DBC). Urine samples from 15 participants revealed the presence of ADBC in 5, TBC in 11, and DBC in all samples, with DBC concentrations pointedly higher than the other metabolites. These metabolites show promise as biomarkers for ATBC exposure, though further validation with human data is required. Our results underscore the need for comprehensive studies on ATBC metabolism, exposure pathways, and urinary excretion to accurately assess human exposure levels.
Collapse
Affiliation(s)
- Hyeri Jeon
- Department of Health, Environment & Safety, Eulji University, 553 Sanseong-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13135, Republic of Korea
| | - Sunghoon Yeo
- Department of Health, Environment & Safety, Eulji University, 553 Sanseong-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13135, Republic of Korea
| | - Eun-Ah Park
- Department of Health, Environment & Safety, Eulji University, 553 Sanseong-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13135, Republic of Korea
| | - Daeho Kang
- Department of Environmental Engineering, Changwon National University, 20 Changwondaehak-ro, Uichang-gu, Changwon-si, 51140, Republic of Korea
| | - Kailin Shen
- Department of Environmental Engineering, Changwon National University, 20 Changwondaehak-ro, Uichang-gu, Changwon-si, 51140, Republic of Korea
| | - Minyoung Kim
- Department of Chemistry, Sogang University, 35 Baekbeom-ro, Mapo-gu, Seoul, 04107, Republic of Korea
| | - Inhye Lee
- Department of Environmental Health Sciences, School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea
| | - Junho Jeon
- Department of Environmental Engineering, Changwon National University, 20 Changwondaehak-ro, Uichang-gu, Changwon-si, 51140, Republic of Korea; School of Smart and Green Engineering, Changwon National University, Changwon, Gyeongsangnamdo, 51140, Republic of Korea
| | - Bongjin Moon
- Department of Chemistry, Sogang University, 35 Baekbeom-ro, Mapo-gu, Seoul, 04107, Republic of Korea
| | - Kyunghee Ji
- Department of Occupational and Environmental Health, Yongin University, 134 Yongindaehak-ro, Cheoin-gu, Yongin-si, Gyeonggi-do, 17092, Republic of Korea
| | - Sungkyoon Kim
- Graduate School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea
| | - Younglim Kho
- Department of Health, Environment & Safety, Eulji University, 553 Sanseong-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, 13135, Republic of Korea.
| |
Collapse
|
3
|
Gerofke A, Lange R, Vogel N, Schmidt P, Weber T, David M, Frederiksen H, Baken K, Govarts E, Gilles L, Martin LR, Martinsone Ž, Santonen T, Schoeters G, Scheringer M, Domínguez-Romero E, López ME, Calvo AC, Koch HM, Apel P, Kolossa-Gehring M. Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU. Int J Hyg Environ Health 2024; 259:114378. [PMID: 38631089 DOI: 10.1016/j.ijheh.2024.114378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Revised: 04/07/2024] [Accepted: 04/07/2024] [Indexed: 04/19/2024]
Abstract
Phthalates and the substitute plasticizer DINCH belong to the first group of priority substances investigated by the European Human Biomonitoring Initiative (HBM4EU) to answer policy-relevant questions and safeguard an efficient science-to-policy transfer of results. Human internal exposure levels were assessed using two data sets from all European regions and Israel. The first collated existing human biomonitoring (HBM) data (2005-2019). The second consisted of new data generated in the harmonized "HBM4EU Aligned Studies" (2014-2021) on children and teenagers for the ten most relevant phthalates and DINCH, accompanied by a quality assurance/quality control (QA/QC) program for 17 urinary exposure biomarkers. Exposures differed between countries, European regions, age groups and educational levels. Toxicologically derived Human biomonitoring guidance values (HBM-GVs) were exceeded in up to 5% of the participants of the HBM4EU Aligned Studies. A mixture risk assessment (MRA) including five reprotoxic phthalates (DEHP, DnBP, DiBP, BBzP, DiNP) revealed that for about 17% of the children and teenagers, health risks cannot be excluded. Concern about male reproductive health emphasized the need to include other anti-androgenic substances for MRA. Contaminated food and the use of personal care products were identified as relevant exposure determinants paving the way for new regulatory measures. Time trend analyses verified the efficacy of regulations: especially for the highly regulated phthalates exposure dropped significantly, while levels of the substitutes DINCH and DEHTP increased. The HBM4EU e-waste study, however, suggests that workers involved in e-waste management may be exposed to higher levels of restricted phthalates. Exposure-effect association studies indicated the relevance of a range of endpoints. A set of HBM indicators was derived to facilitate and accelerate science-to-policy transfer. Result indicators allow different groups and regions to be easily compared. Impact indicators allow health risks to be directly interpreted. The presented results enable successful science-to-policy transfer and support timely and targeted policy measures.
Collapse
Affiliation(s)
- Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
| | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Nina Vogel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Phillipp Schmidt
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Till Weber
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Madlen David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100, Copenhagen, Denmark; International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital-Rigshospitalet, 2100, Copenhagen, Denmark
| | - Kirsten Baken
- Brabant Advies, Brabantlaan 3, 5216 TV 's, Hertogenbosch, the Netherlands
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | | | - Žanna Martinsone
- Institute of Occupational Safety and Environmental Health, Rīga Stradiņš University, Dzirciema 16, LV-1007, Riga, Latvia
| | - Tiina Santonen
- Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032, Tyoterveyslaitos, Finland
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; University of Antwerp, Toxicological Center, Universiteitsplein 1, 2610, Wilrijk, Belgium; Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - Martin Scheringer
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, 611 37, Czech Republic
| | - Elena Domínguez-Romero
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, 611 37, Czech Republic
| | - Marta Esteban López
- Environmental Toxicology Unit, National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), 28220, Majadahonda, Spain
| | - Argelia Castaño Calvo
- Environmental Toxicology Unit, National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), 28220, Majadahonda, Spain
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | |
Collapse
|
4
|
Reale E, Zare Jeddi M, Paini A, Connolly A, Duca R, Cubadda F, Benfenati E, Bessems J, S Galea K, Dirven H, Santonen T, M Koch H, Jones K, Sams C, Viegas S, Kyriaki M, Campisi L, David A, Antignac JP, B Hopf N. Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment. ENVIRONMENT INTERNATIONAL 2024; 184:108474. [PMID: 38350256 DOI: 10.1016/j.envint.2024.108474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 12/15/2023] [Accepted: 02/01/2024] [Indexed: 02/15/2024]
Abstract
Human health risk assessment is historically built upon animal testing, often following Organisation for Economic Co-operation and Development (OECD) test guidelines and exposure assessments. Using combinations of human relevant in vitro models, chemical analysis and computational (in silico) approaches bring advantages compared to animal studies. These include a greater focus on the human species and on molecular mechanisms and kinetics, identification of Adverse Outcome Pathways and downstream Key Events as well as the possibility of addressing susceptible populations and additional endpoints. Much of the advancement and progress made in the Next Generation Risk Assessment (NGRA) have been primarily focused on new approach methodologies (NAMs) and physiologically based kinetic (PBK) modelling without incorporating human biomonitoring (HBM). The integration of toxicokinetics (TK) and PBK modelling is an essential component of NGRA. PBK models are essential for describing in quantitative terms the TK processes with a focus on the effective dose at the expected target site. Furthermore, the need for PBK models is amplified by the increasing scientific and regulatory interest in aggregate and cumulative exposure as well as interactions of chemicals in mixtures. Since incorporating HBM data strengthens approaches and reduces uncertainties in risk assessment, here we elaborate on the integrated use of TK, PBK modelling and HBM in chemical risk assessment highlighting opportunities as well as challenges and limitations. Examples are provided where HBM and TK/PBK modelling can be used in both exposure assessment and hazard characterization shifting from external exposure and animal dose/response assays to animal-free, internal exposure-based NGRA.
Collapse
Affiliation(s)
- Elena Reale
- Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland
| | - Maryam Zare Jeddi
- National Institute for Public Health and the Environment (RIVM), the Netherlands
| | | | - Alison Connolly
- UCD Centre for Safety & Health at Work, School of Public Health, Physiotherapy, and Sports Science, University College Dublin, D04 V1W8, Dublin, Ireland for Climate and Air Pollution Studies, Physics, School of Natural Science and the Ryan Institute, National University of Ireland, University Road, Galway H91 CF50, Ireland
| | - Radu Duca
- Unit Environmental Hygiene and Human Biological Monitoring, Department of Health Protection, Laboratoire national de santé (LNS), 1, Rue Louis Rech, 3555 Dudelange, Luxembourg; Environment and Health, Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 35, 3000 Leuven, Belgium
| | - Francesco Cubadda
- Istituto Superiore di Sanità - National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
| | - Emilio Benfenati
- Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy
| | - Jos Bessems
- VITO HEALTH, Flemish Institute for Technological Research, 2400 Mol, Belgium
| | - Karen S Galea
- Institute of Occupational Medicine (IOM), Research Avenue North, Riccarton, Edinburgh EH14 4AP, UK
| | - Hubert Dirven
- Department of Climate and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Tiina Santonen
- Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032 Työterveyslaitos, Finland
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Kate Jones
- HSE - Health and Safety Executive, Harpur Hill, Buxton SK17 9JN, UK
| | - Craig Sams
- HSE - Health and Safety Executive, Harpur Hill, Buxton SK17 9JN, UK
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon, Lisbon, Portugal
| | - Machera Kyriaki
- Benaki Phytopathological Institute, 8, Stephanou Delta Street, 14561 Kifissia, Athens, Greece
| | - Luca Campisi
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy; Flashpoint srl, Via Norvegia 56, 56021 Cascina (PI), Italy
| | - Arthur David
- Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, F-35000 Rennes, France
| | | | - Nancy B Hopf
- Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.
| |
Collapse
|
5
|
Cleys P, Hardy E, Ait Bamai Y, Poma G, Cseresznye A, Malarvannan G, Scheepers PTJ, Viegas S, Porras SP, Santonen T, Godderis L, Verdonck J, Poels K, Martins C, João Silva M, Louro H, Martinsone I, Akūlova L, van Nieuwenhuyse A, Graumans M, Mahiout S, Duca RC, Covaci A. HBM4EU e-waste study: Occupational exposure of electronic waste workers to phthalates and DINCH in Europe. Int J Hyg Environ Health 2024; 255:114286. [PMID: 37951141 DOI: 10.1016/j.ijheh.2023.114286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 10/06/2023] [Accepted: 10/23/2023] [Indexed: 11/13/2023]
Abstract
Workers involved in the processing of electronic waste (e-waste) are potentially exposed to toxic chemicals, including phthalates and alternative plasticizers (APs). Dismantling and shredding of e-waste may lead to the production of dust that contains these plasticizers. The aim of this study, which was part of the European Human Biomonitoring Initiative (HBM4EU), was to assess the exposure to phthalates (e.g. di-(2-ethylhexyl) phthalate (DEHP), diethyl phthalate (DEP), di-butyl phthalate (DBP), butyl-benzyl phthalate (BBzP), di-isononyl phthalate (DiNP), di-isodecyl phthalate (DiDP) and cyclohexane-1,2-dicarboxylic di-isononyl ester (DINCH) in e-waste workers from ten European companies. This was achieved by (i) analysing urine samples from 106 e-waste workers collected at the beginning and at the end of the work week, (ii) comparing these with urine samples from 63 non-occupationally exposed controls, and (iii) analysing settled floor dust collected in e-waste premises. Significantly higher urinary concentrations of seven out of thirteen phthalates and DINCH metabolites were found in the e-waste workers compared to the control population. However, no significant differences were found between pre- and post-shift concentrations in the e-waste workers. Concentrations of DBP, DEHP and DiDP in dust were weakly to moderately positively correlated with their corresponding urinary metabolite concentrations in the e-waste workers (Spearman's ρ = 0.4, 0.3 and 0.2, respectively). Additionally, significantly lower urinary concentrations of nine phthalates and DINCH metabolites were found in e-waste workers using respiratory protective equipment (RPE) during their work activities, reflecting the potential benefits of RPE to prevent occupational exposure to phthalates and DINCH. The estimated daily intake (EDI) values obtained in this study were lower than the corresponding tolerable daily intake (TDI) adopted by the European Food Safety Authority (EFSA) for the general population, suggesting that the risk for negative health consequences in this population of e-waste workers from exposure to phthalates and DINCH is expected to be low. This was confirmed by the urinary metabolite concentrations of all workers being lower than the HBM4EU guidance values derived for the occupational exposed and general population. This study is one of the first to address the occupational exposure to phthalates and DINCH in Europe in e-waste dismantling workers, combining a human biomonitoring approach with analysis of settled indoor dust.
Collapse
Affiliation(s)
- Paulien Cleys
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium.
| | - Emilie Hardy
- Unit for Environmental Hygiene and Human Biological Monitoring, Laboratoire National de Santé, Rue Louis Rech 1, Dudelange, Luxembourg
| | - Yu Ait Bamai
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium; Center for Environmental and Health Sciences, Hokkaido University, Kita 12, Nishi 7, Sapporo, Japan
| | - Giulia Poma
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
| | - Adam Cseresznye
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
| | - Govindan Malarvannan
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium
| | - Paul T J Scheepers
- Radboud Institute for Biological and Environmental Sciences, Radboud University, Heyendaalseweg 135, Nijmegen, the Netherlands
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | - Simo P Porras
- Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, Helsinki, Finland
| | - Tiina Santonen
- Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, Helsinki, Finland
| | - Lode Godderis
- Department of Public Health and Primary Care, Environment and Health, KU Leuven, Herestraat 49, Leuven, Belgium; Idewe, External Service for Prevention and Protection at Work, Interleuvenlaan 58, 3001, Heverlee, Belgium
| | - Jelle Verdonck
- Department of Public Health and Primary Care, Environment and Health, KU Leuven, Herestraat 49, Leuven, Belgium
| | - Katrien Poels
- Department of Public Health and Primary Care, Environment and Health, KU Leuven, Herestraat 49, Leuven, Belgium
| | - Carla Martins
- NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | - Maria João Silva
- National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, 1099-085, Lisbon, Portugal
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, 1099-085, Lisbon, Portugal
| | - Inese Martinsone
- Laboratory of Hygiene and Occupational Diseases, Institute of Occupational Safety and Environmental Health, Rīga Stradiņš University, Dzirciema Street 16, Rīga, Latvia
| | - Lāsma Akūlova
- Laboratory of Hygiene and Occupational Diseases, Institute of Occupational Safety and Environmental Health, Rīga Stradiņš University, Dzirciema Street 16, Rīga, Latvia
| | - An van Nieuwenhuyse
- Unit for Environmental Hygiene and Human Biological Monitoring, Laboratoire National de Santé, Rue Louis Rech 1, Dudelange, Luxembourg; Department of Public Health and Primary Care, Environment and Health, KU Leuven, Herestraat 49, Leuven, Belgium
| | - Martien Graumans
- Radboud Institute for Biological and Environmental Sciences, Radboud University, Heyendaalseweg 135, Nijmegen, the Netherlands
| | - Selma Mahiout
- Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, Helsinki, Finland
| | - Radu Corneliu Duca
- Unit for Environmental Hygiene and Human Biological Monitoring, Laboratoire National de Santé, Rue Louis Rech 1, Dudelange, Luxembourg; Department of Public Health and Primary Care, Environment and Health, KU Leuven, Herestraat 49, Leuven, Belgium
| | - Adrian Covaci
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, Wilrijk, Belgium.
| |
Collapse
|
6
|
Ketema RM, Kasper-Sonnenberg M, Ait Bamai Y, Miyashita C, Koch HM, Pälmke C, Kishi R, Ikeda A. Exposure Trends to the Non-phthalate Plasticizers DEHTP, DINCH, and DEHA in Children from 2012 to 2017: The Hokkaido Study. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2023; 57:11926-11936. [PMID: 37506071 DOI: 10.1021/acs.est.3c03172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/30/2023]
Abstract
Phthalates owing to their endocrine-disrupting effects are regulated in certain products, leading to their replacement with substitutions such as di-2-ethylhexyl terephthalate (DEHTP), 1,2-cyclohexane dicarboxylic acid di(isononyl) ester (DINCH), and di(2-ethylhexyl) adipate (DEHA). However, information on human exposure to these substitutes, especially in susceptible subpopulations such as children, is limited. Thus, we examined the levels and exposure trends of DEHTP, DINCH, and DEHA metabolites in 7 year-old Japanese school children. In total, 180 urine samples collected from 2012 to 2017 were used to quantify 10 DEHTP, DINCH, and DEHA metabolites via isotope dilution liquid chromatography with tandem mass spectrometry. DEHTP and DINCH metabolites were detected in 95.6 and 92.2% of the children, respectively, and DEHA was not detected. This study, annually conducted between 2012 and 2017, revealed a significant (p < 0.05) 5-fold increase in DEHTP metabolites and a 2-fold increase in DINCH metabolites. However, the maximum estimated internal exposures were still below the health-based guidance and toxicological reference values. Exposure levels to DEHTP and DINCH have increased considerably in Japanese school children. DEHA is less relevant. Future studies are warranted to closely monitor the increasing trend in different aged and larger populations and identify the potential health effects and sources contributing to increasing exposure and intervene if necessary.
Collapse
Affiliation(s)
- Rahel Mesfin Ketema
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
- Faculty of Health Sciences, Hokkaido University, North 12, West 5, Sapporo 060-0812, Japan
| | - Monika Kasper-Sonnenberg
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, Bochum 44789, Germany
| | - Yu Ait Bamai
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
- Toxicological Center, University of Antwerp, Universiteitsplein 1, Wilrijk 2610, Belgium
| | - Chihiro Miyashita
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, Bochum 44789, Germany
| | - Claudia Pälmke
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, Bochum 44789, Germany
| | - Reiko Kishi
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
| | - Atsuko Ikeda
- Center for Environmental and Health Sciences, Hokkaido University, North 12, West 7, Sapporo 060-0812, Japan
- Faculty of Health Sciences, Hokkaido University, North 12, West 5, Sapporo 060-0812, Japan
| |
Collapse
|
7
|
Pineda S, Lignell S, Gyllenhammar I, Lampa E, Benskin JP, Lundh T, Lindh C, Kiviranta H, Glynn A. Exposure of Swedish adolescents to elements, persistent organic pollutants (POPs), and rapidly excreted substances - The Riksmaten adolescents 2016-17 national survey. Int J Hyg Environ Health 2023; 251:114196. [PMID: 37279611 DOI: 10.1016/j.ijheh.2023.114196] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Revised: 05/24/2023] [Accepted: 05/26/2023] [Indexed: 06/08/2023]
Abstract
Adolescence is a period of significant physiological changes, and likely a sensitive window to chemical exposure. Few nation-wide population-based studies of chemical body burdens in adolescents have been published. In the national dietary survey Riksmaten Adolescents (RMA) 2016-17, over 13 chemical substance groups, including elements, chlorinated/brominated/fluorinated persistent organic pollutants (POPs) were analysed in blood, and in urine metabolites of phthalates/phthalate alternatives, phosphorous flame retardants, polycyclic aromatic hydrocarbons (PAHs), and pesticides, along with bisphenols and biocide/preservative/antioxidant/UV filter substances (N = 1082, ages 11-21). The aim was to characterize the body burdens in a representative population of adolescents in Sweden, and to compare results with human biomonitoring guidance values (HBM-GVs). Cluster analyses and Spearman's rank order correlations suggested that concentrations of substances with known common exposure sources and similar toxicokinetics formed obvious clusters and showed moderate to very strong correlations (r ≥ 0.4). No clusters were formed between substances from different matrices. Geometric mean (GM) concentrations of the substances were generally less than 3-fold different from those observed among adolescents in NHANES (USA 2015-16) and GerES V (Germany 2014-17). Notable exceptions were brominated diphenyl ethers (PBDEs) with >20-fold lower GM concentrations, and the biocide triclosan and ultraviolet (UV) filter benzophenone-3 with >15-fold lower mean concentrations in RMA compared to NHANES. Exceedance of the most conservative HBM-GVs were observed for aluminium (Al, 26% of subjects), perfluorooctanesulfonic acid (PFOS, 19%), perfluorooctanoic acid (PFOA, 12%), lead (Pb, 12%), MBP (dibutyl phthalate metabolite, 4.8%), hexachlorobenzene (HCB, 3.1%) and 3-phenoxybenzoic acid (PBA, pyrethroid metabolite, 2.2%). Males showed a higher proportion of exceedances than females for Pb, HCB and PFOS; otherwise no gender-related differences in exceedances were observed. A higher proportion of males than females had a Hazard Index (HI) of substances with liver and kidney toxicity and neurotoxicity >1. Industrialized countries with similarly high standards of living, with some exceptions, show comparable average body burdens of a variety of toxic chemicals among adolescents from the general population. The exceedances of HBM-GVs and HIs strongly suggests that further efforts to limit chemical exposure are warranted.
Collapse
Affiliation(s)
- Sebastian Pineda
- Department of Biomedicine and Veterinary Public Health Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
| | - Sanna Lignell
- Department of Risk and Benefit Assessment, Swedish National Food Agency, Uppsala, Sweden
| | - Irina Gyllenhammar
- Department of Risk and Benefit Assessment, Swedish National Food Agency, Uppsala, Sweden
| | - Erik Lampa
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden
| | - Jonathan P Benskin
- Department of Environmental Science, Stockholm University, Stockholm, Sweden
| | - Thomas Lundh
- Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden
| | - Christian Lindh
- Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden
| | - Hannu Kiviranta
- Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
| | - Anders Glynn
- Department of Biomedicine and Veterinary Public Health Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden
| |
Collapse
|
8
|
Sjöström Y, Hagström K, Lindh C, Bryngelsson IL, Larsson M, Hagberg J. Exposure to phthalates and DiNCH among preschool children in Sweden: Urinary metabolite concentrations and predictors of exposure. Int J Hyg Environ Health 2023; 250:114161. [PMID: 36990000 DOI: 10.1016/j.ijheh.2023.114161] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 03/16/2023] [Accepted: 03/17/2023] [Indexed: 03/29/2023]
Abstract
Several plasticizing chemicals induce endocrine disrupting effects in humans, and the indoor environment is suggested to be a source of exposure. As children are particularly vulnerable to the effects from exposure to endocrine disrupting chemicals (EDCs), it is essential to monitor exposure to EDCs such as phthalates and non-phthalate plasticizers in indoor environments intended for use by children. The aim of this study was to assess everyday plasticizer exposure among preschool-aged children in Sweden by measuring urinary plasticizer metabolite concentrations. In addition, it was investigated whether the concentrations would be altered as a result of the children spending part of the day at preschool, in comparison with weekend exposure, when they may spend more time in home environments or engage in various weekend and leisure activities. For this purpose, fourteen metabolites from eight phthalates (di-ethylhexyl phthalate, DEHP; di-n-butyl phthalate, DnBP; di-isobutyl phthalate, DiBP; butyl-benzyl phthalate, BBzP; di-iso-nonyl phthalate, DiNP; di-propylheptyl phthalate, DPHP; di-iso-decyl phthalate, DiDP; and di-ethyl phthalate, DEP) and one non-phthalate plasticizer (di-isononyl cyclohexane 1,2-dicarboxylate, DiNCH) were measured in 206 urine samples collected at four occasions, i.e. twice during the winter and twice during the spring from 54 children (mean 5.1 years, SD 0.94) enrolled at eight preschools in Sweden. A detection frequency (DF) of 99.9% for the 14 metabolites indicates a widespread exposure to plasticizers among children in Sweden. Compared to previous Swedish and international studies performed during approximately the same time period, high urinary concentrations of monobenzyl phthalate (MBzP), a metabolite from the strictly regulated BBzP, were measured in this study (median 17 ng/mL). Overall, high urinary phthalate metabolite concentrations were observed in this study compared to the US CDC-NHANES from the same time period and similar age-group. Compared to European studies, however, similar concentrations were observed for most metabolites and the urinary concentrations from few participating children exceeded the human biomonitoring guidance values (HBM-GV) for children. After days with preschool attendance, lower urinary concentrations of metabolites originating from DEP and phthalates that are strictly regulated within the EU REACH legislation (DEHP, DnBP, and DiBP) and higher concentrations of metabolites originating from DiNP, DPHP, and DiDP, i.e. less or non-regulated phthalates were found compared the urinary concentrations of these metabolites in weekends. This may indicate that factors in the indoor environment itself are important for the extent of the plasticizer exposure. All the analyzed metabolites were measured in lower concentrations in urine collected from children attending preschools built or renovated after the year 2000, while no seasonal differences were observed in this study.
Collapse
|
9
|
Loh MM, Schmidt P, Christopher de Vries Y, Vogel N, Kolossa-Gehring M, Vlaanderen J, Lebret E, Luijten M. Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept. TOXICS 2023; 11:toxics11050408. [PMID: 37235224 DOI: 10.3390/toxics11050408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/19/2023] [Revised: 03/25/2023] [Accepted: 03/29/2023] [Indexed: 05/28/2023]
Abstract
Chemical mixture risk assessment has, in the past, primarily focused on exposures quantified in the external environment. Assessing health risks using human biomonitoring (HBM) data provides information on the internal concentration, from which a dose can be derived, of chemicals to which human populations are exposed. This study describes a proof of concept for conducting mixture risk assessment with HBM data, using the population-representative German Environmental Survey (GerES) V as a case study. We first attempted to identify groups of correlated biomarkers (also known as 'communities', reflecting co-occurrence patterns of chemicals) using a network analysis approach (n = 515 individuals) on 51 chemical substances in urine. The underlying question is whether the combined body burden of multiple chemicals is of potential health concern. If so, subsequent questions are which chemicals and which co-occurrence patterns are driving the potential health risks. To address this, a biomonitoring hazard index was developed by summing over hazard quotients, where each biomarker concentration was weighted (divided) by the associated HBM health-based guidance value (HBM-HBGV, HBM value or equivalent). Altogether, for 17 out of the 51 substances, health-based guidance values were available. If the hazard index was higher than 1, then the community was considered of potential health concern and should be evaluated further. Overall, seven communities were identified in the GerES V data. Of the five mixture communities where a hazard index was calculated, the highest hazard community contained N-Acetyl-S-(2-carbamoyl-ethyl)cysteine (AAMA), but this was the only biomarker for which a guidance value was available. Of the other four communities, one included the phthalate metabolites mono-isobutyl phthalate (MiBP) and mono-n-butyl phthalate (MnBP) with high hazard quotients, which led to hazard indices that exceed the value of one in 5.8% of the participants included in the GerES V study. This biological index method can put forward communities of co-occurrence patterns of chemicals on a population level that need further assessment in toxicology or health effects studies. Future mixture risk assessment using HBM data will benefit from additional HBM health-based guidance values based on population studies. Additionally, accounting for different biomonitoring matrices would provide a wider range of exposures. Future hazard index analyses could also take a common mode of action approach, rather than the more agnostic and non-specific approach we have taken in this proof of concept.
Collapse
Affiliation(s)
- Miranda M Loh
- Institute of Occupational Medicine-IOM, Edinburgh EH14 4AP, UK
| | | | | | - Nina Vogel
- German Environment Agency (UBA), 14195 Berlin, Germany
| | | | - Jelle Vlaanderen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands
| | - Erik Lebret
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands
- Center for Sustainability, Environment and Health, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands
| | - Mirjam Luijten
- Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands
| |
Collapse
|
10
|
Vogel N, Schmidt P, Lange R, Gerofke A, Sakhi AK, Haug LS, Jensen TK, Frederiksen H, Szigeti T, Csákó Z, Murinova LP, Sidlovska M, Janasik B, Wasowicz W, Tratnik JS, Mazej D, Gabriel C, Karakitsios S, Barbone F, Rosolen V, Rambaud L, Riou M, Murawski A, Leseman D, Koppen G, Covaci A, Lignell S, Lindroos AK, Zvonar M, Andryskova L, Fabelova L, Richterova D, Horvat M, Kosjek T, Sarigiannis D, Maroulis M, Pedraza-Diaz S, Cañas A, Verheyen VJ, Bastiaensen M, Gilles L, Schoeters G, Esteban-López M, Castaño A, Govarts E, Koch HM, Kolossa-Gehring M. Current exposure to phthalates and DINCH in European children and adolescents - Results from the HBM4EU Aligned Studies 2014 to 2021. Int J Hyg Environ Health 2023; 249:114101. [PMID: 36805185 DOI: 10.1016/j.ijheh.2022.114101] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 12/02/2022] [Accepted: 12/08/2022] [Indexed: 02/19/2023]
Abstract
Phthalates are mainly used as plasticizers for polyvinyl chloride (PVC). Exposure to several phthalates is associated with different adverse effects most prominently on the development of reproductive functions. The HBM4EU Aligned Studies (2014-2021) have investigated current European exposure to ten phthalates (DEP, BBzP, DiBP, DnBP, DCHP, DnPeP, DEHP, DiNP, DiDP, DnOP) and the substitute DINCH to answer the open policy relevant questions which were defined by HBM4EU partner countries and EU institutions as the starting point of the programme. The exposure dataset includes ∼5,600 children (6-11 years) and adolescents (12-18 years) from up to 12 countries per age group and covering the North, East, South and West European regions. Study data from participating studies were harmonised with respect to sample size and selection of participants, selection of biomarkers, and quality and comparability of analytical results to provide a comparable perspective of European exposure. Phthalate and DINCH exposure were deduced from urinary excretions of metabolites, where concentrations were expressed as their key descriptor geometric mean (GM) and 95th percentile (P95). This study aims at reporting current exposure levels and differences in these between European studies and regions, as well as comparisons to human biomonitoring guidance values (HBM-GVs). GMs for children were highest for ∑DEHP metabolites (33.6 μg/L), MiBP (26.6 μg/L), and MEP (24.4 μg/L) and lowest for∑DiDP metabolites (1.91 μg/L) and ∑DINCH metabolites (3.57 μg/L). In adolescents highest GMs were found for MEP (43.3 μg/L), ∑DEHP metabolites (28.8 μg/L), and MiBP (25.6 μg/L) and lowest for ∑DiDP metabolites (= 2.02 μg/L) and ∑DINCH metabolites (2.51 μg/L). In addition, GMs and P95 stratified by European region, sex, household education level, and degree of urbanization are presented. Differences in average biomarker concentrations between sampling sites (data collections) ranged from factor 2 to 9. Compared to the European average, children in the sampling sites OCC (Denmark), InAirQ (Hungary), and SPECIMEn (The Netherlands) had the lowest concentrations across all metabolites and ESTEBAN (France), NAC II (Italy), and CROME (Greece) the highest. For adolescents, comparably higher metabolite concentrations were found in NEB II (Norway), PCB cohort (Slovakia), and ESTEBAN (France), and lower concentrations in POLAES (Poland), FLEHS IV (Belgium), and GerES V-sub (Germany). Multivariate analyses (Survey Generalized Linear Models) indicate compound-specific differences in average metabolite concentrations between the four European regions. Comparison of individual levels with HBM-GVs revealed highest rates of exceedances for DnBP and DiBP, with up to 3 and 5%, respectively, in children and adolescents. No exceedances were observed for DEP and DINCH. With our results we provide current, detailed, and comparable data on exposure to phthalates in children and - for the first time - in adolescents, and - for the first time - on DINCH in children and adolescents of all four regions of Europe which are particularly suited to inform exposure and risk assessment and answer open policy relevant questions.
Collapse
Affiliation(s)
- Nina Vogel
- German Environment Agency (UBA), Berlin, Germany.
| | | | - Rosa Lange
- German Environment Agency (UBA), Berlin, Germany
| | | | | | - Line S Haug
- Norwegian Institute of Public Health, Oslo, Norway
| | - Tina Kold Jensen
- IST - Clinical Pharmacology, Pharmacy and Environmental Medicine, Odense, Denmark
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
| | | | - Zsófia Csákó
- National Public Health Center, Budapest, Hungary
| | | | | | - Beata Janasik
- Nofer Institute of Occupational Medicine, Lodz, Poland
| | | | - Janja Snoj Tratnik
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Darja Mazej
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece
| | - Spyros Karakitsios
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece
| | - Fabio Barbone
- Department of Medicine-DAME, University of Udine, Udine, Italy
| | - Valentina Rosolen
- Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", Trieste, Italy
| | - Loïc Rambaud
- Santé publique France, Environmental and Occupational Health Division, Saint-Maurice, France
| | - Margaux Riou
- Santé publique France, Environmental and Occupational Health Division, Saint-Maurice, France
| | | | - Daan Leseman
- National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Adrian Covaci
- Toxicological Center, University of Antwerp, Wilrijk, Belgium
| | | | | | - Martin Zvonar
- RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
| | - Lenka Andryskova
- RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic
| | - Lucia Fabelova
- Slovak Medical University, Faculty of Public Health, Bratislava, Slovakia
| | - Denisa Richterova
- Slovak Medical University, Faculty of Public Health, Bratislava, Slovakia
| | - Milena Horvat
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Tina Kosjek
- Jozef Stefan Institute, Department of Environmental Sciences, Ljubljana, Slovenia
| | - Denis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece; Environmental Health Engineering, Institute of Advanced Study, Pavia, Italy
| | - Marios Maroulis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Thessaloniki-Thermi, Greece
| | - Susana Pedraza-Diaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Ana Cañas
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Veerle J Verheyen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | | | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences and Toxicological Centre, Antwerp, Belgium
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany
| | | |
Collapse
|
11
|
Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021). Int J Hyg Environ Health 2023; 249:114119. [PMID: 36773580 DOI: 10.1016/j.ijheh.2023.114119] [Citation(s) in RCA: 30] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 12/19/2022] [Accepted: 01/24/2023] [Indexed: 02/11/2023]
Abstract
As one of the core elements of the European Human Biomonitoring Initiative (HBM4EU) a human biomonitoring (HBM) survey was conducted in 23 countries to generate EU-wide comparable HBM data. This survey has built on existing HBM capacity in Europe by aligning national or regional HBM studies, referred to as the HBM4EU Aligned Studies. The HBM4EU Aligned Studies included a total of 10,795 participants of three age groups: (i) 3,576 children aged 6-12 years, (ii) 3,117 teenagers aged 12-18 years and (iii) 4,102 young adults aged 20-39 years. The participants were recruited between 2014 and 2021 in 11-12 countries per age group, geographically distributed across Europe. Depending on the age group, internal exposure to phthalates and the substitute DINCH, halogenated and organophosphorus flame retardants, per- and polyfluoroalkyl substances (PFASs), cadmium, bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, acrylamide, mycotoxins (deoxynivalenol (total DON)), benzophenones and selected pesticides was assessed by measuring substance specific biomarkers subjected to stringent quality control programs for chemical analysis. For substance groups analyzed in different age groups higher average exposure levels were observed in the youngest age group, i.e., phthalates/DINCH in children versus teenagers, acrylamide and pesticides in children versus adults, benzophenones in teenagers versus adults. Many biomarkers in teenagers and adults varied significantly according to educational attainment, with higher exposure levels of bisphenols, phthalates, benzophenones, PAHs and acrylamide in participants (from households) with lower educational attainment, while teenagers from households with higher educational attainment have higher exposure levels for PFASs and arsenic. In children, a social gradient was only observed for the non-specific pyrethroid metabolite 3-PBA and di-isodecyl phthalate (DiDP), with higher levels in children from households with higher educational attainment. Geographical variations were seen for all exposure biomarkers. For 15 biomarkers, the available health-based HBM guidance values were exceeded with highest exceedance rates for toxicologically relevant arsenic in teenagers (40%), 3-PBA in children (36%), and between 11 and 14% for total DON, Σ (PFOA + PFNA + PFHxS + PFOS), bisphenol S and cadmium. The infrastructure and harmonized approach succeeded in obtaining comparable European wide internal exposure data for a prioritized set of 11 chemical groups. These data serve as a reference for comparison at the global level, provide a baseline to compare the efficacy of the European Commission's chemical strategy for sustainability and will give leverage to national policy makers for the implementation of targeted measures.
Collapse
|
12
|
Santonen T, Mahiout S, Alvito P, Apel P, Bessems J, Bil W, Borges T, Bose-O'Reilly S, Buekers J, Cañas Portilla AI, Calvo AC, de Alba González M, Domínguez-Morueco N, López ME, Falnoga I, Gerofke A, Caballero MDCG, Horvat M, Huuskonen P, Kadikis N, Kolossa-Gehring M, Lange R, Louro H, Martins C, Meslin M, Niemann L, Díaz SP, Plichta V, Porras SP, Rousselle C, Scholten B, Silva MJ, Šlejkovec Z, Tratnik JS, Joksić AŠ, Tarazona JV, Uhl M, Van Nieuwenhuyse A, Viegas S, Vinggaard AM, Woutersen M, Schoeters G. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU. Int J Hyg Environ Health 2023; 249:114139. [PMID: 36870229 DOI: 10.1016/j.ijheh.2023.114139] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 02/13/2023] [Accepted: 02/14/2023] [Indexed: 03/06/2023]
Abstract
One of the aims of the European Human Biomonitoring Initiative, HBM4EU, was to provide examples of and good practices for the effective use of human biomonitoring (HBM) data in human health risk assessment (RA). The need for such information is pressing, as previous research has indicated that regulatory risk assessors generally lack knowledge and experience of the use of HBM data in RA. By recognising this gap in expertise, as well as the added value of incorporating HBM data into RA, this paper aims to support the integration of HBM into regulatory RA. Based on the work of the HBM4EU, we provide examples of different approaches to including HBM in RA and in estimations of the environmental burden of disease (EBoD), the benefits and pitfalls involved, information on the important methodological aspects to consider, and recommendations on how to overcome obstacles. The examples are derived from RAs or EBoD estimations made under the HBM4EU for the following HBM4EU priority substances: acrylamide, o-toluidine of the aniline family, aprotic solvents, arsenic, bisphenols, cadmium, diisocyanates, flame retardants, hexavalent chromium [Cr(VI)], lead, mercury, mixture of per-/poly-fluorinated compounds, mixture of pesticides, mixture of phthalates, mycotoxins, polycyclic aromatic hydrocarbons (PAHs), and the UV-filter benzophenone-3. Although the RA and EBoD work presented here is not intended to have direct regulatory implications, the results can be useful for raising awareness of possibly needed policy actions, as newly generated HBM data from HBM4EU on the current exposure of the EU population has been used in many RAs and EBoD estimations.
Collapse
Affiliation(s)
| | | | - Paula Alvito
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; Centre for Environmental and Marine Studies (CESAM), University of Aveiro, 3810-193 Aveiro, Portugal
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Jos Bessems
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | - Wieneke Bil
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Teresa Borges
- General-Directorate of Health, Ministry of Health, 1049-005, Lisbon, Portugal
| | - Stephan Bose-O'Reilly
- Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - Private University for Health Sciences, Medical Informations und Technology, Hall i.T., Austria
| | - Jurgen Buekers
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | | | - Argelia Castaño Calvo
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | | | - Marta Esteban López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | - Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | | | | | | | | | | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | - Carla Martins
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | - Matthieu Meslin
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Lars Niemann
- German Federal Institute for Risk Assessment, Berlin, Germany
| | - Susana Pedraza Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Veronika Plichta
- Austrian Agency for Health and Food Safety, Department Risk Assessment, Spargelfeldstraße 191, 1220, Vienna, Austria
| | | | - Christophe Rousselle
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Bernice Scholten
- Research Group Risk Analysis for Products in Development, The Netherlands Organisation for Applied Scientific research (TNO), Utrecht, the Netherlands
| | - Maria João Silva
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | | | | | | | - Jose V Tarazona
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain; European Food Safety Authority (EFSA), Parma, Italy
| | - Maria Uhl
- Environment Agency Austria, Spittelauer Lände 5, 1090, Vienna, Austria
| | | | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | | | - Marjolijn Woutersen
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Greet Schoeters
- VITO-Flemish Institute for Technological Research, Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences, Antwerp, Belgium
| |
Collapse
|
13
|
Apel P, Lamkarkach F, Lange R, Sissoko F, David M, Rousselle C, Schoeters G, Kolossa-Gehring M. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results. Int J Hyg Environ Health 2023; 248:114097. [PMID: 36577283 DOI: 10.1016/j.ijheh.2022.114097] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Revised: 12/01/2022] [Accepted: 12/02/2022] [Indexed: 12/27/2022]
Abstract
The European Initiative HBM4EU aimed to further establish human biomonitoring across Europe as an important tool for determining population exposure to chemicals and as part of health-related risk assessments, thus making it applicable for policy advice. Not only should analytical methods and survey design be harmonized and quality assured, but also the evaluation of human biomonitoring data. For the health-related interpretation of the data within HBM4EU, a strategy for deriving health-based human biomonitoring guidance values (HBM-GVs) for both the general population and workers was agreed on. On this basis, HBM-GVs for exposure biomarkers of 1,2-cyclohexane dicarboxylic acid diisononyl ester (DINCH), phthalates (diethyl hexyl phthalate (DEHP), di-n-butyl phthalate (DnBP), diisobutyl phthalate (DiBP), butyl benzyl phthalate (BBzP), and bis-(2-propylheptyl) phthalate (DPHP)), bisphenols A and S, pyrethroids (deltamethrin and cyfluthrin), solvents (1-methyl-2-pyrrolidone (NMP), 1-ethylpyrrolidin-2-one (NEP), N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC)), the heavy metal cadmium and the mycotoxin deoxynivalenol (DON) were developed and assigned a level of confidence. The approach to HBM-GV derivations, results, and limitations in data interpretation with special focus on the pyrethroids are presented in this paper.
Collapse
Affiliation(s)
- P Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
| | - F Lamkarkach
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, France
| | - R Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - F Sissoko
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, France
| | - M David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - C Rousselle
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, France
| | - G Schoeters
- VITO Health, Flemish Institute for Technological Research, 2400, Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, 2610, Antwerp, Belgium
| | - M Kolossa-Gehring
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| |
Collapse
|
14
|
Vogel N, Frederiksen H, Lange R, Jørgensen N, Koch HM, Weber T, Andersson AM, Kolossa-Gehring M. Urinary excretion of phthalates and the substitutes DINCH and DEHTP in Danish young men and German young adults between 2000 and 2017 - A time trend analysis. Int J Hyg Environ Health 2023; 248:114080. [PMID: 36657282 DOI: 10.1016/j.ijheh.2022.114080] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Revised: 11/23/2022] [Accepted: 11/24/2022] [Indexed: 01/18/2023]
Abstract
Over the last twenty-five years it has become evident that exposure to several phthalates can have adverse effects on human health, such as endocrine disruption. This led to a series of EU regulations that resulted in a decrease in the production volumes of the restricted phthalates and an increased production of substitutes. The current study describes the impact of regulations and changes in production and use of phthalates and their substitutes on internal exposure patterns in two European populations since the beginning of the 2000'ies. Using harmonised data from young adults in Denmark (Danish Young Men Study, n = 1,063, spot urine) and Germany (Environmental Specimen Bank, n = 878, 24-h urine) with repeated cross-sectional design (3-11 cycles per biomarker) we applied Locally Estimated Scatterplot Smoothing (LOESS) and Generalized Linear Models (GLMs) to estimate time trends and the role of covariates on the trend (e.g. age, BMI). Time trends of daily excretion (μg/24h) are comparable between the two samples for the regulated (DEHP, BBzP, DiNP, DnBP, DiBP, DiDP/DPHP) as well as the non-regulated substances (DMP, DEP, DINCH, DEHTP) although the rate of change differ for some of the compounds. GLM results indicate that the daily excretion of the most regulated phthalates has decreased over time (DEHP yearly about 12-16%, BBzP 5%, DnBP 0.3-17%, and DiBP 4-12%). Interestingly, also the non-regulated phthalates DMP and DEP decreased by 6-18% per year. In sharp contrast, the phthalate substitutes DINCH and DEHTP show very steep annual increases (∼10-68% and ∼100%, respectively) between 2009 and 2017. We did not find an effect of age, sex, BMI, or education on the time trend. The present study provides comparable insights into how exposure to phthalates and two of their substitutes have changed over the last two decades in Germany and Denmark.
Collapse
Affiliation(s)
- Nina Vogel
- German Environment Agency (UBA), Berlin, Germany.
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Denmark
| | - Rosa Lange
- German Environment Agency (UBA), Berlin, Germany
| | - Niels Jørgensen
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Denmark
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany
| | - Till Weber
- German Environment Agency (UBA), Berlin, Germany
| | - Anna-Maria Andersson
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Denmark
| | | |
Collapse
|
15
|
Gerofke A, David M, Schmidt P, Vicente JL, Buekers J, Gilles L, Colles A, Bessems J, Bastiaensen M, Covaci A, Den Hond E, Koppen G, Laeremans M, Verheyen VJ, Černá M, Klánová J, Krsková A, Zvonař M, Knudsen LE, Koch HM, Jensen TK, Rambaud L, Riou M, Vogel N, Gabriel C, Karakitsios S, Papaioannou N, Sarigiannis D, Kakucs R, Középesy S, Rudnai P, Szigeti T, Barbone F, Rosolen V, Guignard C, Gutleb AC, Sakhi AK, Haug LS, Janasik B, Ligocka D, Estokova M, Fabelova L, Kolena B, Murinova LP, Petrovicova I, Richterova D, Horvat M, Mazej D, Tratnik JS, Runkel AA, Castaño A, Esteban-López M, Pedraza-Díaz S, Åkesson A, Lignell S, Vlaanderen J, Zock JP, Schoeters G, Kolossa-Gehring M. From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure. Int J Hyg Environ Health 2023; 247:114073. [PMID: 36434900 PMCID: PMC9758616 DOI: 10.1016/j.ijheh.2022.114073] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 10/19/2022] [Accepted: 11/07/2022] [Indexed: 11/25/2022]
Abstract
Within the European Human Biomonitoring (HBM) Initiative HBM4EU we derived HBM indicators that were designed to help answering key policy questions and support chemical policies. The result indicators convey information on chemicals exposure of different age groups, sexes, geographical regions and time points by comparing median exposure values. If differences are observed for one group or the other, policy measures or risk management options can be implemented. Impact indicators support health risk assessment by comparing exposure values with health-based guidance values, such as human biomonitoring guidance values (HBM-GVs). In general, the indicators should be designed to translate complex scientific information into short and clear messages and make it accessible to policy makers but also to a broader audience such as stakeholders (e.g. NGO's), other scientists and the general public. Based on harmonized data from the HBM4EU Aligned Studies (2014-2021), the usefulness of our indicators was demonstrated for the age group children (6-11 years), using two case examples: one phthalate (Diisobutyl phthalate: DiBP) and one non-phthalate substitute (Di-isononyl cyclohexane-1,2- dicarboxylate: DINCH). For the comparison of age groups, these were compared to data for teenagers (12-18 years), and time periods were compared using data from the DEMOCOPHES project (2011-2012). Our result indicators proved to be suitable for demonstrating the effectiveness of policy measures for DiBP and the need of continuous monitoring for DINCH. They showed similar exposure for boys and girls, indicating that there is no need for gender focused interventions and/or no indication of sex-specific exposure patterns. They created a basis for a targeted approach by highlighting relevant geographical differences in internal exposure. An adequate data basis is essential for revealing differences for all indicators. This was particularly evident in our studies on the indicators on age differences. The impact indicator revealed that health risks based on exposure to DiBP cannot be excluded. This is an indication or flag for risk managers and policy makers that exposure to DiBP still is a relevant health issue. HBM indicators derived within HBM4EU are a valuable and important complement to existing indicator lists in the context of environment and health. Their applicability, current shortcomings and solution strategies are outlined.
Collapse
Affiliation(s)
- Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany,Corresponding author.
| | - Madlen David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Phillipp Schmidt
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Joana Lobo Vicente
- European Environment Agency, Kongens Nytorv 6, 1050, Copenhagen, Denmark
| | - Jurgen Buekers
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Liese Gilles
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Ann Colles
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Jos Bessems
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | | | - Adrian Covaci
- Toxicological Center, University of Antwerp, 2610 Wilrijk, Belgium
| | | | - Gudrun Koppen
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Michelle Laeremans
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Veerle J. Verheyen
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | - Milena Černá
- National Institute of Public Health, Prague, Czech Republic
| | - Jana Klánová
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Andrea Krsková
- National Institute of Public Health, Prague, Czech Republic
| | - Martin Zvonař
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic,Faculty of Sport Studies, Masaryk University, Kamenice 753/5, Brno, Czech Republic
| | - Lisbeth E. Knudsen
- Department of Public Health, University of Copenhagen Øster Farimagsgade 5 DK Copenhagen, Denmark
| | - Holger M. Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance − Institute of the Ruhr University Bochum (IPA), 44789, Bochum, Germany
| | - Tina Kold Jensen
- Faculty of Health Sciences, Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark
| | - Loïc Rambaud
- Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France
| | - Margaux Riou
- Santé publique France, French Public Health Agency (SpFrance), Saint-Maurice, France
| | - Nina Vogel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Spyros Karakitsios
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Nafsika Papaioannou
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Denis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece,Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto - Piazza Della Vittoria 15, 27100, Pavia, Italy
| | - Réka Kakucs
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Szilvia Középesy
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Péter Rudnai
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Tamás Szigeti
- National Public Health Center, Albert Flórián út 2-6., 1097, Budapest, Hungary
| | - Fabio Barbone
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100, Udine, Italy
| | - Valentina Rosolen
- Institute for Maternal and Child Health - IRCCS "Burlo Garofolo", 34137, Trieste, Italy
| | - Cedric Guignard
- Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg
| | - Arno C. Gutleb
- Luxembourg Institute of Science and Technology (LIST), Environmental Research and Innovation (ERIN) Department, 41, rue du Brill, L-4422 Belvaux, Luxembourg
| | | | | | - Beata Janasik
- Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland
| | - Danuta Ligocka
- Nofer Institute of Occupational Medicine, St. Teresy 8, Lodz, Poland
| | - Milada Estokova
- Public Health Authority of the Slovak Republic, Trnavska cesta 52, 826 45, Bratislava, Slovakia
| | - Lucia Fabelova
- Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia
| | - Branislav Kolena
- Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia
| | | | - Ida Petrovicova
- Constantine the Philosopher University in Nitra, Tr. A Hlinku 1, 94901 Nitra, Slovakia
| | - Denisa Richterova
- Slovak Medical University, Faculty of Public Health, Limbova 12, 83303 Bratislava, Slovakia
| | - Milena Horvat
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Darja Mazej
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Janja Snoj Tratnik
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Agneta Annika Runkel
- Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Susana Pedraza-Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Agneta Åkesson
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Sanna Lignell
- Swedish Food Agency, PO Box 622, SE-751 26, Uppsala, Sweden
| | - Jelle Vlaanderen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands
| | - Jan-Paul Zock
- National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
| | - Greet Schoeters
- VITO – Flemish Institute for Technological Research, Unit Health, Boeretang 200, 2400, Mol, Belgium
| | | |
Collapse
|
16
|
van der Schyff V, Kalina J, Govarts E, Gilles L, Schoeters G, Castaño A, Esteban-López M, Kohoutek J, Kukučka P, Covaci A, Koppen G, Andrýsková L, Piler P, Klánová J, Jensen TK, Rambaud L, Riou M, Lamoree M, Kolossa-Gehring M, Vogel N, Weber T, Göen T, Gabriel C, Sarigiannis DA, Sakhi AK, Haug LS, Murinova LP, Fabelova L, Tratnik JS, Mazej D, Melymuk L. Exposure to flame retardants in European children - Results from the HBM4EU aligned studies. Int J Hyg Environ Health 2023; 247:114070. [PMID: 36442457 PMCID: PMC9758617 DOI: 10.1016/j.ijheh.2022.114070] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 09/29/2022] [Accepted: 11/03/2022] [Indexed: 11/26/2022]
Abstract
Many legacy and emerging flame retardants (FRs) have adverse human and environmental health effects. This study reports legacy and emerging FRs in children from nine European countries from the HBM4EU aligned studies. Studies from Belgium, Czech Republic, Germany, Denmark, France, Greece, Slovenia, Slovakia, and Norway conducted between 2014 and 2021 provided data on FRs in blood and urine from 2136 children. All samples were collected and analyzed in alignment with the HBM4EU protocols. Ten halogenated FRs were quantified in blood, and four organophosphate flame retardants (OPFR) metabolites quantified in urine. Hexabromocyclododecane (HBCDD) and decabromodiphenyl ethane (DBDPE) were infrequently detected (<16% of samples). BDE-47 was quantified in blood from Greece, France, and Norway, with France (0.36 ng/g lipid) having the highest concentrations. BDE-153 and -209 were detected in <40% of samples. Dechlorane Plus (DP) was quantified in blood from four countries, with notably high median concentrations of 16 ng/g lipid in Slovenian children. OPFR metabolites had a higher detection frequency than other halogenated FRs. Diphenyl phosphate (DPHP) was quantified in 99% of samples across 8 countries at levels ∼5 times higher than other OPFR metabolites (highest median in Slovenia of 2.43 ng/g lipid). FR concentrations were associated with lifestyle factors such as cleaning frequency, employment status of the father of the household, and renovation status of the house, among others. The concentrations of BDE-47 in children from this study were similar to or lower than FRs found in adult matrices in previous studies, suggesting lower recent exposure and effectiveness of PBDE restrictions.
Collapse
Affiliation(s)
| | - Jiři Kalina
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium,Department of Biomedical Sciences, University of Antwerp, 2020, Antwerp, Belgium
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Jiři Kohoutek
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Petr Kukučka
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Adrian Covaci
- Toxicological Center, University of Antwerp, 2610 Wilrijk, Belgium
| | - Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium
| | - Lenka Andrýsková
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Pavel Piler
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Jana Klánová
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Tina Kold Jensen
- Department of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, 5000, Denmark
| | - Loic Rambaud
- Santé Publique France, French Public Health Agency (ANSP), Saint-Maurice, 94415, France
| | - Margaux Riou
- Santé Publique France, French Public Health Agency (ANSP), Saint-Maurice, 94415, France
| | - Marja Lamoree
- Vrije Universiteit, Amsterdam Institute for Life and Environment, Section Chemistry for Environment & Health, De Boelelaan 1108, 1081 HZ, Amsterdam, Netherlands
| | | | - Nina Vogel
- German Environment Agency (UBA), 06844 Dessau-Roßlau, Germany
| | - Till Weber
- German Environment Agency (UBA), 06844 Dessau-Roßlau, Germany
| | - Thomas Göen
- IPASUM - Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestrasse 9-11, 91054, Erlangen, Germany
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Dimosthenis A. Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece,Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto, Piazza Della Vittoria 15, 27100, Pavia, Italy
| | - Amrit Kaur Sakhi
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Line Småstuen Haug
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | | | - Lucia Fabelova
- Faculty of Public Health, Slovak Medical University, Bratislava, 833 03, Slovakia
| | - Janja Snoj Tratnik
- Department of Environmental Sciences, Jožef Stefan Institute, Ljubljana, 1000, Slovenia
| | - Darja Mazej
- Department of Environmental Sciences, Jožef Stefan Institute, Ljubljana, 1000, Slovenia
| | - Lisa Melymuk
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic,Corresponding author.
| |
Collapse
|
17
|
Zare Jeddi M, Hopf NB, Louro H, Viegas S, Galea KS, Pasanen-Kase R, Santonen T, Mustieles V, Fernandez MF, Verhagen H, Bopp SK, Antignac JP, David A, Mol H, Barouki R, Audouze K, Duca RC, Fantke P, Scheepers P, Ghosh M, Van Nieuwenhuyse A, Lobo Vicente J, Trier X, Rambaud L, Fillol C, Denys S, Conrad A, Kolossa-Gehring M, Paini A, Arnot J, Schulze F, Jones K, Sepai O, Ali I, Brennan L, Benfenati E, Cubadda F, Mantovani A, Bartonova A, Connolly A, Slobodnik J, Bruinen de Bruin Y, van Klaveren J, Palmen N, Dirven H, Husøy T, Thomsen C, Virgolino A, Röösli M, Gant T, von Goetz N, Bessems J. Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020-2030. ENVIRONMENT INTERNATIONAL 2022; 168:107476. [PMID: 36067553 DOI: 10.1016/j.envint.2022.107476] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Revised: 07/28/2022] [Accepted: 08/12/2022] [Indexed: 06/15/2023]
Abstract
Human biomonitoring (HBM) is a crucial approach for exposure assessment, as emphasised in the European Commission's Chemicals Strategy for Sustainability (CSS). HBM can help to improve chemical policies in five major key areas: (1) assessing internal and aggregate exposure in different target populations; 2) assessing exposure to chemicals across life stages; (3) assessing combined exposure to multiple chemicals (mixtures); (4) bridging regulatory silos on aggregate exposure; and (5) enhancing the effectiveness of risk management measures. In this strategy paper we propose a vision and a strategy for the use of HBM in chemical regulations and public health policy in Europe and beyond. We outline six strategic objectives and a roadmap to further strengthen HBM approaches and increase their implementation in the regulatory risk assessment of chemicals to enhance our understanding of exposure and health impacts, enabling timely and targeted policy interventions and risk management. These strategic objectives are: 1) further development of sampling strategies and sample preparation; 2) further development of chemical-analytical HBM methods; 3) improving harmonisation throughout the HBM research life cycle; 4) further development of quality control / quality assurance throughout the HBM research life cycle; 5) obtain sustained funding and reinforcement by legislation; and 6) extend target-specific communication with scientists, policymakers, citizens and other stakeholders. HBM approaches are essential in risk assessment to address scientific, regulatory and societal challenges. HBM requires full and strong support from the scientific and regulatory domain to reach its full potential in public and occupational health assessment and in regulatory decision-making.
Collapse
Affiliation(s)
- Maryam Zare Jeddi
- National Institute for Public Health and the Environment (RIVM), the Netherlands.
| | - Nancy B Hopf
- Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, Department of Human Genetics, Lisbon and ToxOmics - Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, 1600-560 Lisbon, Portugal; Comprehensive Health Research Center (CHRC), 1169-056 Lisbon, Portugal
| | - Karen S Galea
- Institute of Occupational Medicine (IOM), Research Avenue North, Riccarton, Edinburgh EH14 4AP, UK
| | - Robert Pasanen-Kase
- State Secretariat for Economic Affairs (SECO), Labour Directorate Section Chemicals and Work (ABCH), Switzerland
| | - Tiina Santonen
- Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032 Työterveyslaitos, Finland
| | - Vicente Mustieles
- University of Granada, Center for Biomedical Research (CIBM), School of Medicine, Department of Radiology and Physical Medicine, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain
| | - Mariana F Fernandez
- University of Granada, Center for Biomedical Research (CIBM), School of Medicine, Department of Radiology and Physical Medicine, Granada, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain
| | - Hans Verhagen
- University of Ulster, Coleraine, Northern Ireland, National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
| | | | | | - Arthur David
- Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, F-35000 Rennes, France
| | - Hans Mol
- Wageningen Food Safety Research - part of Wageningen University & Research, Wageningen, the Netherlands
| | - Robert Barouki
- Université Paris Cité, T3S, Inserm Unit 1124, 45 rue des Saints Pères, 75006 Paris, France
| | - Karine Audouze
- Université Paris Cité, T3S, Inserm Unit 1124, 45 rue des Saints Pères, 75006 Paris, France
| | - Radu-Corneliu Duca
- Department of Health Protection, Laboratoire national de santé (LNS), 1, Rue Louis Rech, 3555 Dudelange, Luxembourg; Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
| | - Peter Fantke
- Quantitative Sustainability Assessment, Department of Environmental and Resource Engineering, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
| | - Paul Scheepers
- Radboud Institute for Biological and Environmental Sciences, Radboud University, Nijmegen, the Netherlands
| | - Manosij Ghosh
- Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
| | - An Van Nieuwenhuyse
- Department of Health Protection, Laboratoire national de santé (LNS), 1, Rue Louis Rech, 3555 Dudelange, Luxembourg; Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
| | - Joana Lobo Vicente
- EEA - European Environment Agency, Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Xenia Trier
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Loïc Rambaud
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Clémence Fillol
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - Sebastien Denys
- SPF - Santé Publique France, Environmental and Occupational Health Division, France
| | - André Conrad
- German Environment Agency (Umweltbundesamt), Dessau-Roßlau/Berlin, Germany
| | | | - Alicia Paini
- European Commission, Joint Research Centre (JRC), Ispra, Italy
| | - Jon Arnot
- ARC Arnot Research and Consulting, Inc., Toronto ONM4M 1W4, Canada
| | - Florian Schulze
- European Center for Environmental Medicine, Weserstr. 165, 12045 Berlin, Germany
| | - Kate Jones
- HSE - Health and Safety Executive, Harpur Hill, Buxton SK17 9JN, UK
| | | | | | - Lorraine Brennan
- School of Agriculture and Food Science, Institute of Food and Health, University College Dublin, Dublin, Ireland
| | - Emilio Benfenati
- Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy
| | - Francesco Cubadda
- Istituto Superiore di Sanità - National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
| | - Alberto Mantovani
- Istituto Superiore di Sanità - National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
| | - Alena Bartonova
- NILU Norwegian Institute for Air Research, 2027 Kjeller, Norway
| | - Alison Connolly
- Centre for Climate and Air Pollution Studies, Physics, School of Natural Science and the Ryan Institute, University of Galway, University Road, Galway H91 CF50, Ireland
| | - Jaroslav Slobodnik
- NORMAN Association, Rue Jacques Taffanel - Parc Technologique ALATA, 60550 Verneuil-en-Halatte, France
| | - Yuri Bruinen de Bruin
- Commission, Joint Research Centre, Directorate for Space, Security and Migration, Geel, Belgium
| | - Jacob van Klaveren
- National Institute for Public Health and the Environment (RIVM), the Netherlands
| | - Nicole Palmen
- National Institute for Public Health and the Environment (RIVM), the Netherlands
| | - Hubert Dirven
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Trine Husøy
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Cathrine Thomsen
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Ana Virgolino
- Environmental Health Behaviour Lab, Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal; Laboratório Associado TERRA, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal
| | - Martin Röösli
- Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute (Swiss TPH), CH-4123 Allschwil, Switzerland
| | - Tim Gant
- Center for Radiation, Chemical and Environmental Hazards, Public Health England, UK
| | | | - Jos Bessems
- VITO HEALTH, Flemish Institute for Technological Research, 2400 Mol, Belgium
| |
Collapse
|
18
|
Rosolen V, Giordani E, Mariuz M, Parpinel M, Ronfani L, Vecchi Brumatti L, Bin M, Calamandrei G, Mustieles V, Gilles L, Govarts E, Baken K, Rodriguez Martin L, Schoeters G, Sepai O, Sovcikova E, Fabelova L, Šidlovská M, Kolena B, Kold Jensen T, Frederiksen H, Kolossa-Gehring M, Lange R, Apel P, Castano A, Esteban López M, Jacobs G, Voorspoels S, Jurdáková H, Górová R, Barbone F. Concurrent Assessment of Phthalates/HEXAMOLL ® DINCH Exposure and Wechsler Intelligence Scale for Children Performance in Three European Cohorts of the HBM4EU Aligned Studies. TOXICS 2022; 10:538. [PMID: 36136503 PMCID: PMC9502751 DOI: 10.3390/toxics10090538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 08/31/2022] [Accepted: 09/13/2022] [Indexed: 06/16/2023]
Abstract
Information about the effects of phthalates and non-phthalate substitute cyclohexane-1,2-dicarboxylic acid diisononyl ester (HEXAMOLL® DINCH) on children's neurodevelopment is limited. The aim of the present research is to evaluate the association between phthalate/HEXAMOLL® DINCH exposure and child neurodevelopment in three European cohorts involved in HBM4EU Aligned Studies. Participating subjects were school-aged children belonging to the Northern Adriatic cohort II (NAC-II), Italy, Odense Child Cohort (OCC), Denmark, and PCB cohort, Slovakia. In each cohort, children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score (FSIQ) of the Wechsler Intelligence Scale of Children test using three different editions. The children's urine samples, collected for one point in time concurrently with the neurodevelopmental evaluation, were analyzed for several phthalates/HEXAMOLL® DINCH biomarkers. The relation between phthalates/HEXAMOLL® DINCH and FSIQ was explored by applying separate multiple linear regressions in each cohort. The means and standard deviations of FSIQ were 109 ± 11 (NAC-II), 98 ± 12 (OCC), and 81 ± 15 (PCB cohort). In NAC-II, direct associations between FSIQ and DEHP's biomarkers were found: 5OH-MEHP+5oxo-MEHP (β = 2.56; 95% CI 0.58-4.55; N = 270), 5OH-MEHP+5cx-MEPP (β = 2.48; 95% CI 0.47-4.49; N = 270) and 5OH-MEHP (β = 2.58; 95% CI 0.65-4.51; N = 270). On the contrary, in the OCC the relation between DEHP's biomarkers and FSIQ tended to be inverse but imprecise (p-value ≥ 0.10). No associations were found in the PCB cohort. FSIQ was not associated with HEXAMOLL® DINCH in any cohort. In conclusion, these results do not provide evidence of an association between concurrent phthalate/DINCHHEXAMOLLR DINCH exposure and IQ in children.
Collapse
Affiliation(s)
- Valentina Rosolen
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Elisa Giordani
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
| | - Marika Mariuz
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
| | - Maria Parpinel
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
| | - Luca Ronfani
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Liza Vecchi Brumatti
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Maura Bin
- Institute for Maternal and Child Health, IRCCS “Burlo Garofolo”, Via dell’Istria 65/1, 34137 Trieste, Italy
| | - Gemma Calamandrei
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | - Vicente Mustieles
- Center for Biomedical Research, University of Granada, 18011 Granada, Spain
- Instituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain
- Consortium for Biomedical Research in Epidemiology and Public Health, 28029 Madrid, Spain
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | - Kirsten Baken
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
| | | | - Eva Sovcikova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
| | - Lucia Fabelova
- Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
| | - Miroslava Šidlovská
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nabrezie mladeze 91, 94974 Nitra, Slovakia
| | - Branislav Kolena
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nabrezie mladeze 91, 94974 Nitra, Slovakia
| | - Tina Kold Jensen
- Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, Institute of Public Health, University of Southern Denmark, 5000 Odense, Denmark
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
- International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark
| | | | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195 Berlin, Germany
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195 Berlin, Germany
| | - Argelia Castano
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Marta Esteban López
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28029 Madrid, Spain
| | - Griet Jacobs
- Unit Separation and Conversion Technology, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium
| | - Stefan Voorspoels
- Unit Separation and Conversion Technology, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium
| | - Helena Jurdáková
- Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, Mlynská Dolina, 84215 Bratislava, Slovakia
| | - Renáta Górová
- Department of Analytical Chemistry, Faculty of Natural Sciences, Comenius University, Ilkovičova 6, Mlynská Dolina, 84215 Bratislava, Slovakia
| | - Fabio Barbone
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy
- Institute of Hygiene and Clinical Epidemiology, Azienda Sanitaria Universitaria Friuli Centrale, Via Colugna 50, 33100 Udine, Italy
| |
Collapse
|
19
|
Lange R, Vogel N, Schmidt P, Gerofke A, Luijten M, Bil W, Santonen T, Schoeters G, Gilles L, Sakhi AK, Haug LS, Jensen TK, Frederiksen H, Koch HM, Szigeti T, Szabados M, Tratnik JS, Mazej D, Gabriel C, Sarigiannis D, Dzhedzheia V, Karakitsios S, Rambaud L, Riou M, Koppen G, Covaci A, Zvonař M, Piler P, Klánová J, Fábelová L, Richterová D, Kosjek T, Runkel A, Pedraza-Díaz S, Verheyen V, Bastiaensen M, Esteban-López M, Castaño A, Kolossa-Gehring M. Cumulative risk assessment of five phthalates in European children and adolescents. Int J Hyg Environ Health 2022; 246:114052. [DOI: 10.1016/j.ijheh.2022.114052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 10/06/2022] [Accepted: 10/06/2022] [Indexed: 11/06/2022]
|
20
|
[Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2022; 65:936-939. [PMID: 35997778 PMCID: PMC9436871 DOI: 10.1007/s00103-022-03578-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/01/2022] [Indexed: 11/24/2022]
Abstract
Beim Human-Biomonitoring wird die innere Schadstoffbelastung des Menschen aus verschiedenen Quellen wie Nahrung, Alltagsgegenständen oder Atemluft erfasst, indem z. B. Blut und Urin analysiert werden. Um das Human-Biomonitoring in Europa zu fördern und zu koordinieren, wurde 2017 das Projekt „Human-Biomonitoring für Europa“ (HBM4EU) begonnen, an dem sich 30 Länder, die Europäische Umweltagentur und die Europäische Kommission beteiligt haben. Im Juni 2022 wurde das Projekt abgeschlossen. Vergleichbare und zuverlässige Belastungsdaten konnten für eine breite Palette von Umweltchemikalien erfasst und einheitlich bewertet werden. Weitere wichtige Erfolge der Initiative waren die Etablierung eines Kontrollprogramms zur Qualitätssicherung, ein Konzept zur Vereinheitlichung zukünftiger HBM-Studien, eine gemeinsame Strategie zur Ableitung von gesundheitsbezogenen Beurteilungswerten (HBM Guidance Values – HBM-GVs) und die Einrichtung nationaler Gremien. Die gewonnenen Belastungsdaten sind über die Informationsplattform für die Überwachung von Chemikalien (IPCHEM) und das EU HBM-Dashboard zugänglich. Publikationen sind über die HBM4EU-Onlinebibliothek frei verfügbar. Insgesamt zeigen die Ergebnisse, dass die Belastungen der EU-Bevölkerung für viele Chemikalien wie etwa Phthalate und perfluorierte Alkylsubstanzen (PFAS) zu hoch sind und weiterhin Handlungsbedarf seitens der Politik besteht. Das im Projekt HBM4EU generierte Wissen kann die politischen Entscheidungsträger:innen bei der Verbesserung der Chemikalien‑, Umwelt- und Gesundheitspolitik unterstützen.
Collapse
|
21
|
Tarazona JV, Cattaneo I, Niemann L, Pedraza-Diaz S, González-Caballero MC, de Alba-Gonzalez M, Cañas A, Dominguez-Morueco N, Esteban-López M, Castaño A, Borges T, Katsonouri A, Makris KC, Ottenbros I, Mol H, De Decker A, Morrens B, Berman T, Barnett-Itzhaki Z, Probst-Hensch N, Fuhrimann S, Tratnik JS, Horvat M, Rambaud L, Riou M, Schoeters G, Govarts E, Kolossa-Gehring M, Weber T, Apel P, Namorado S, Santonen T. A Tiered Approach for Assessing Individual and Combined Risk of Pyrethroids Using Human Biomonitoring Data. TOXICS 2022; 10:toxics10080451. [PMID: 36006130 PMCID: PMC9416723 DOI: 10.3390/toxics10080451] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Revised: 07/29/2022] [Accepted: 08/01/2022] [Indexed: 12/04/2022]
Abstract
Pyrethroids are a major insecticide class, suitable for biomonitoring in humans. Due to similarities in structure and metabolic pathways, urinary metabolites are common to various active substances. A tiered approach is proposed for risk assessment. Tier I was a conservative screening for overall pyrethroid exposure, based on phenoxybenzoic acid metabolites. Subsequently, probabilistic approaches and more specific metabolites were used for refining the risk estimates. Exposure was based on 95th percentiles from HBM4EU aligned studies (2014–2021) covering children in Belgium, Cyprus, France, Israel, Slovenia, and The Netherlands and adults in France, Germany, Israel, and Switzerland. In all children populations, the 95th percentiles for 3-phenoxybenzoic acid (3-PBA) exceeded the screening value. The probabilistic refinement quantified the risk level of the most exposed population (Belgium) at 2% or between 1–0.1% depending on the assumptions. In the substance specific assessments, the 95th percentiles of urinary concentrations in the aligned studies were well below the respective human biomonitoring guidance values (HBM-GVs). Both information sets were combined for refining the combined risk. Overall, the HBM data suggest a low health concern, at population level, related to pyrethroid exposure for the populations covered by the studies, even though a potential risk for highly exposed children cannot be completely excluded. The proposed tiered approach, including a screening step and several refinement options, seems to be a promising tool of scientific and regulatory value in future.
Collapse
Affiliation(s)
- Jose V. Tarazona
- European Food Safety Authority (EFSA), 43126 Parma, Italy
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
- Correspondence: (J.V.T.); (T.S.)
| | - Irene Cattaneo
- European Food Safety Authority (EFSA), 43126 Parma, Italy
| | - Lars Niemann
- Department of Safety of Pesticides, German Federal Institute for Risk Assessment, 10589 Berlin, Germany
| | - Susana Pedraza-Diaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | | | | | - Ana Cañas
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | | | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | - Teresa Borges
- General-Directorate of Health, Ministry of Health, 1049-005 Lisbon, Portugal
| | | | - Konstantinos C. Makris
- Cyprus International Institute for Environmental and Public Health, Cyprus University of Technology, Limassol 3036, Cyprus
| | - Ilse Ottenbros
- National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 Bilthoven, The Netherlands
| | - Hans Mol
- Wageningen Food Safety Research (WFSR), 6700 Wageningen, The Netherlands
| | | | - Bert Morrens
- Department of Sociology, University of Antwerp, 2020 Antwerpen, Belgium
| | | | - Zohar Barnett-Itzhaki
- Ruppin Research Group in Environmental and Social Sustainability, Ruppin Academic Center, Emek Hefer 4025000, Israel
| | - Nicole Probst-Hensch
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland
| | - Samuel Fuhrimann
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland
| | - Janja Snoj Tratnik
- Jozef Stefan Institute, Department of Environmental Sciences, 1000 Jubljana, Slovenia
| | - Milena Horvat
- Jozef Stefan Institute, Department of Environmental Sciences, 1000 Jubljana, Slovenia
| | - Loic Rambaud
- Department of Environmental and Occupational Health, Santé Publique France, 12 rue du Val d’Osne, Saint-Maurice, CEDEX, 94415 Paris, France
| | - Margaux Riou
- Department of Environmental and Occupational Health, Santé Publique France, 12 rue du Val d’Osne, Saint-Maurice, CEDEX, 94415 Paris, France
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2020 Mol, Belgium
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2020 Mol, Belgium
| | | | - Till Weber
- German Environment Agency (UBA), 14195 Berlin, Germany
| | - Petra Apel
- German Environment Agency (UBA), 14195 Berlin, Germany
| | - Sonia Namorado
- Department of Epidemiology, National Institute of Health Dr. Ricardo Jorge, Avenida Padre Cruz, 1649-016 Lisbon, Portugal
| | - Tiina Santonen
- Finnish Institute of Occupational Health, Työterveyslaitos, P.O. Box 40, 00032 Helsinki, Finland
- Correspondence: (J.V.T.); (T.S.)
| |
Collapse
|
22
|
Tarazona JV, González-Caballero MDC, de Alba-Gonzalez M, Pedraza-Diaz S, Cañas A, Dominguez-Morueco N, Esteban-López M, Cattaneo I, Katsonouri A, Makris KC, Halldorsson TI, Olafsdottir K, Zock JP, Dias J, Decker AD, Morrens B, Berman T, Barnett-Itzhaki Z, Lindh C, Gilles L, Govarts E, Schoeters G, Weber T, Kolossa-Gehring M, Santonen T, Castaño A. Improving the Risk Assessment of Pesticides through the Integration of Human Biomonitoring and Food Monitoring Data: A Case Study for Chlorpyrifos. TOXICS 2022; 10:toxics10060313. [PMID: 35736921 PMCID: PMC9228629 DOI: 10.3390/toxics10060313] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Revised: 05/26/2022] [Accepted: 05/30/2022] [Indexed: 02/05/2023]
Abstract
The risk assessment of pesticide residues in food is a key priority in the area of food safety. Most jurisdictions have implemented pre-marketing authorization processes, which are supported by prospective risk assessments. These prospective assessments estimate the expected residue levels in food combining results from residue trials, resembling the pesticide use patterns, with food consumption patterns, according to internationally agreed procedures. In addition, jurisdictions such as the European Union (EU) have implemented large monitoring programs, measuring actual pesticide residue levels in food, and are supporting large-scale human biomonitoring programs for confirming the actual exposure levels and potential risk for consumers. The organophosphate insecticide chlorpyrifos offers an interesting case study, as in the last decade, its acceptable daily intake (ADI) has been reduced several times following risk assessments by the European Food Safety Authority (EFSA). This process has been linked to significant reductions in the use authorized in the EU, reducing consumers’ exposure progressively, until the final ban in 2020, accompanied by setting all EU maximum residue levels (MRL) in food at the default value of 0.01 mg/kg. We present a comparison of estimates of the consumer’s internal exposure to chlorpyrifos based on the urinary marker 3,5,6-trichloro-2-pyridinol (TCPy), using two sources of monitoring data: monitoring of the food chain from the EU program and biomonitoring of European citizens from the HB4EU project, supported by a literature search. Both methods confirmed a drastic reduction in exposure levels from 2016 onwards. The margin of exposure approach is then used for conducting retrospective risk assessments at different time points, considering the evolution of our understanding of chlorpyrifos toxicity, as well as of exposure levels in EU consumers following the regulatory decisions. Concerns are presented using a color code, and have been identified for almost all studies, particularly for the highest exposed group, but at different levels, reaching the maximum level, red code, for children in Cyprus and Israel. The assessment uncertainties are highlighted and integrated in the identification of levels of concern.
Collapse
Affiliation(s)
- Jose V. Tarazona
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
- European Food Safety Authority (EFSA), I-43126 Parma, Italy;
- Correspondence: (J.V.T.); (A.C.)
| | - Maria del Carmen González-Caballero
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
| | - Mercedes de Alba-Gonzalez
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
| | - Susana Pedraza-Diaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
| | - Ana Cañas
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
| | - Noelia Dominguez-Morueco
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
| | - Irene Cattaneo
- European Food Safety Authority (EFSA), I-43126 Parma, Italy;
| | | | - Konstantinos C. Makris
- Cyprus International Institute for Environmental and Public Health, Cyprus University of Technology, Limassol 3036, Cyprus;
| | - Thorhallur I. Halldorsson
- Faculty of Food Science and Nutrition, School of Health Sciences, University of Iceland, 102 Reykjavik, Iceland;
- Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Kristin Olafsdottir
- Department of Pharmacology and Toxicology, University of Iceland, 107 Reykjavik, Iceland;
| | - Jan-Paul Zock
- National Institute for Public Health and the Environment (RIVM), Bilthoven, 3720 BA De Bilt, The Netherlands;
| | - Jonatan Dias
- Wageningen Food Safety Research (WFSR), 6700 AE Wageningen, The Netherlands;
| | | | - Bert Morrens
- Department of Sociology, University of Antwerp, 2020 Antwerpen, Belgium;
| | - Tamar Berman
- Ministry of Health, Jerusalem 9446724, Israel; (T.B.); (Z.B.-I.)
| | - Zohar Barnett-Itzhaki
- Ministry of Health, Jerusalem 9446724, Israel; (T.B.); (Z.B.-I.)
- Ruppin Research Group in Environmental and Social Sustainability, Ruppin Academic Center, Emek Hefer 4025000, Israel
| | - Christian Lindh
- Division of Occupational and Environmental Medicine, Institute of Laboratory Medicine, Lund University, 22363 Lund, Sweden;
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (E.G.); (G.S.)
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (E.G.); (G.S.)
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (L.G.); (E.G.); (G.S.)
- Department of Biomedical Sciences, University of Antwerp, 2020 Antwerp, Belgium
| | - Till Weber
- German Environment Agency (UBA), 14195 Berlin, Germany; (T.W.); (M.K.-G.)
| | | | - Tiina Santonen
- Finnish Institute of Occupational Health, P.O. Box 40 Helsinki, Finland;
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain; (M.d.C.G.-C.); (M.d.A.-G.); (S.P.-D.); (A.C.); (N.D.-M.); (M.E.-L.)
- Correspondence: (J.V.T.); (A.C.)
| |
Collapse
|
23
|
Mukherjee Das A, Gogia A, Garg M, Elaiyaraja A, Arambam P, Mathur S, Babu-Rajendran R, Deo SVS, Kumar L, Das BC, Janardhanan R. Urinary concentration of endocrine-disrupting phthalates and breast cancer risk in Indian women: A case-control study with a focus on mutations in phthalate-responsive genes. Cancer Epidemiol 2022; 79:102188. [PMID: 35688051 DOI: 10.1016/j.canep.2022.102188] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Revised: 05/09/2022] [Accepted: 05/10/2022] [Indexed: 11/26/2022]
Abstract
BACKGROUND Phthalates are known endocrine-disrupting chemicals used indiscriminately as constituents in consumer products including food processing, and packaging, cosmetics, personal care and household items. Although, few studies have assessed the risk of breast cancer on exposure to phthalates, their association with breast cancer risk in Indian women have not yet been evaluated. METHODS We conducted a case-control study involving 171 participants. Urinary concentrations of six phthalate dieters; DMP (Dimethyl phthalate), DEP (Diethyl phthalate), DBP (Dibutyl phthalate), BBP (benzyl butyl phthalate), DEHP (Di-2-ethyl-hexyl phthalate), DINOP (Di-n-octyl phthalate) were estimated by GC-MS and geometric means were calculated. Univariate and multivariable logistic regression was performed to assess breast cancer risk on exposure to phthalates. Genes responsive to phthalates were identified through literature search and matched with NGS data, and gene-enrichment analysis was performed. RESULTS Significant associations were observed between urinary phthalate concentrations and increased risk of breast cancer for di-butyl phthalate (OR=1.5, 95% CI; 1.06, 2.11, p = 0.002) and di-2-ethyl-hexyl phthalate (>median vs ≤ median; OR=2.97, 95% CI; 1.18, 7.47, p = 0.005) in multivariable analyses. We also found several phthalate-responsive gene mutations in paired breast tumor tissues, which include PTPRD (76.19%), AR (42.86%), CYP1A1 (42.86%), CYP19A1 (23.81%), AHRR (19.05%), PIK3CA (19.05%), CYP1B1 (9.52%), RB1 (9.52%) and MMP9 (9.52%). Gene-enrichment analysis revealed that these genes form a major part of ER/PR, PPAR and HIF-1α-TGF-β signaling cascades involved in breast cancer CONCLUSION: Although the sample size is small, in this first case-control study from India, DBP and DEHP were found to be associated with increased risk of invasive breast cancer and tumor tissues revealed mutations in several phthalate-responsive genes. It is, therefore suggested that human biomonitoring in India and larger studies evaluating the early life genetic and epigenetic alterations on phthalates exposure are required to establish their role in breast carcinogenesis.
Collapse
Affiliation(s)
- Ankan Mukherjee Das
- Laboratory of Disease Dynamics and Molecular Epidemiology, Amity Institute of Public Health, Amity University Uttar Pradesh, Noida, India
| | - Ajay Gogia
- Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
| | - Manoj Garg
- Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine and Stem Cell Research, Amity University Uttar Pradesh, Noida, India
| | - Arun Elaiyaraja
- Ecotoxicology and Toxicogenomics Lab, Department of Environmental Biotechnology, Bharathidasan University, Tamil Nadu, India
| | - Priyadarshini Arambam
- Laboratory of Disease Dynamics and Molecular Epidemiology, Amity Institute of Public Health, Amity University Uttar Pradesh, Noida, India; Batra Hospital and Medical Research Centre, New Delhi, India
| | - Sandeep Mathur
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - Ramaswamy Babu-Rajendran
- Ecotoxicology and Toxicogenomics Lab, Department of Environmental Biotechnology, Bharathidasan University, Tamil Nadu, India
| | - S V S Deo
- Department of Surgical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Lalit Kumar
- Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Bhudev C Das
- Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine and Stem Cell Research, Amity University Uttar Pradesh, Noida, India.
| | - Rajiv Janardhanan
- Laboratory of Disease Dynamics and Molecular Epidemiology, Amity Institute of Public Health, Amity University Uttar Pradesh, Noida, India.
| |
Collapse
|
24
|
Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19116787. [PMID: 35682369 PMCID: PMC9180444 DOI: 10.3390/ijerph19116787] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Accepted: 05/24/2022] [Indexed: 11/17/2022]
Abstract
Human biomonitoring has become a pivotal tool for supporting chemicals’ policies. It provides information on real-life human exposures and is increasingly used to prioritize chemicals of health concern and to evaluate the success of chemical policies. Europe has launched the ambitious REACH program in 2007 to improve the protection of human health and the environment. In October 2020 the EU commission published its new chemicals strategy for sustainability towards a toxic-free environment. The European Parliament called upon the commission to collect human biomonitoring data to support chemical’s risk assessment and risk management. This manuscript describes the organization of the first HBM4EU-aligned studies that obtain comparable human biomonitoring (HBM) data of European citizens to monitor their internal exposure to environmental chemicals. The HBM4EU-aligned studies build on existing HBM capacity in Europe by aligning national or regional HBM studies. The HBM4EU-aligned studies focus on three age groups: children, teenagers, and adults. The participants are recruited between 2014 and 2021 in 11 to 12 primary sampling units that are geographically distributed across Europe. Urine samples are collected in all age groups, and blood samples are collected in children and teenagers. Auxiliary information on socio-demographics, lifestyle, health status, environment, and diet is collected using questionnaires. In total, biological samples from 3137 children aged 6–12 years are collected for the analysis of biomarkers for phthalates, HEXAMOLL® DINCH, and flame retardants. Samples from 2950 teenagers aged 12–18 years are collected for the analysis of biomarkers for phthalates, Hexamoll® DINCH, and per- and polyfluoroalkyl substances (PFASs), and samples from 3522 adults aged 20–39 years are collected for the analysis of cadmium, bisphenols, and metabolites of polyaromatic hydrocarbons (PAHs). The children’s group consists of 50.4% boys and 49.5% girls, of which 44.1% live in cities, 29.0% live in towns/suburbs, and 26.8% live in rural areas. The teenagers’ group includes 50.6% girls and 49.4% boys, with 37.7% of residents in cities, 31.2% in towns/suburbs, and 30.2% in rural areas. The adult group consists of 52.6% women and 47.4% men, 71.9% live in cities, 14.2% in towns/suburbs, and only 13.4% live in rural areas. The study population approaches the characteristics of the general European population based on age-matched EUROSTAT EU-28, 2017 data; however, individuals who obtained no to lower educational level (ISCED 0–2) are underrepresented. The data on internal human exposure to priority chemicals from this unique cohort will provide a baseline for Europe’s strategy towards a non-toxic environment and challenges and recommendations to improve the sampling frame for future EU-wide HBM surveys are discussed.
Collapse
|
25
|
Human Biomonitoring Initiative (HBM4EU): Human Biomonitoring Guidance Values Derived for Dimethylformamide. TOXICS 2022; 10:toxics10060298. [PMID: 35736906 PMCID: PMC9230076 DOI: 10.3390/toxics10060298] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Revised: 05/13/2022] [Accepted: 05/26/2022] [Indexed: 02/04/2023]
Abstract
Within the European Joint Program on Human Biomonitoring HBM4EU, human biomonitoring guidance values (HBM-GVs) for the general population (HBM-GVGenPop) or for occupationally exposed adults (HBM-GVWorker) are derived for prioritized substances including dimethylformamide (DMF). The methodology to derive these values that was agreed upon within the HBM4EU project was applied. A large database on DMF exposure from studies conducted at workplaces provided dose–response relationships between biomarker concentrations and health effects. The hepatotoxicity of DMF has been identified as having the most sensitive effect, with increased liver enzyme concentrations serving as biomarkers of the effect. Out of the available biomarkers of DMF exposure studied in this paper, the following were selected to derive HBM-GVWorker: total N-methylformamide (tNMF) (sum of N-hydroxymethyl-N-methylformamide and NMF) and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) in urine. The proposed HBM-GVWorker is 10 mg·L−1 or 10 mg·g−1 creatinine for both biomarkers. Due to their different half-lives, tNMF (representative of the exposure of the day) and AMCC (representative of the preceding days’ exposure) are complementary for the biological monitoring of workers exposed to DMF. The levels of confidence for these HBM-GVWorker are set to “high” for tNMF and “medium-low” for AMCC. Therefore, further investigations are required for the consolidation of the health-based HBM-GV for AMCC in urine.
Collapse
|
26
|
Socianu S, Bopp SK, Govarts E, Gilles L, Buekers J, Kolossa-Gehring M, Backhaus T, Franco A. Chemical Mixtures in the EU Population: Composition and Potential Risks. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19106121. [PMID: 35627658 PMCID: PMC9141134 DOI: 10.3390/ijerph19106121] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Revised: 05/09/2022] [Accepted: 05/13/2022] [Indexed: 02/04/2023]
Abstract
Regulating chemical mixtures is a complex scientific and policy task. The aim of this study was to investigate typical mixtures and their potential risks based on internal exposure levels in the European population. Based on human biomonitoring (HBM) data made available via the HBM4EU project, we derived generic mixtures representative of a median (P50) and a worst-case scenario (P95) for adults and children. We performed a mixture risk assessment based on HBM concentrations, health-based guidance values (HBGVs) as internal thresholds of concern, and the conservative assumption of concentration addition applied across different toxicological endpoints. Maximum cumulative ratios (MCRs) were calculated to characterize the mixture risk. The mixtures comprise 136 biomarkers for adults and 84 for children, although concentration levels could be quantified only for a fraction of these. Due to limited availability of HBGVs, the mixture risk was assessed for a subset of 20 substance-biomarker pairs for adults and 17 for children. The mixture hazard index ranged from 2.8 (P50, children) to 9.2 (P95, adults). Six to seven substances contributed to over 95% of the total risk. MCR values ranged between 2.6 and 5.5, which is in a similar range as in previous studies based on human external exposures assessments. The limited coverage of substances included in the calculations and the application of a hazard index across toxicological endpoints argue for caution in the interpretation of the results. Nonetheless the analyses of MCR and MAFceiling can help inform a possible mixture assessment factor (MAF) applicable to single substance risk assessment to account for exposure to unintentional mixtures.
Collapse
Affiliation(s)
- Sebastian Socianu
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy; (S.S.); (A.F.)
| | - Stephanie K. Bopp
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy; (S.S.); (A.F.)
- Correspondence: ; Tel.: +39-0332-789950
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (E.G.); (L.G.); (J.B.)
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (E.G.); (L.G.); (J.B.)
| | - Jurgen Buekers
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (E.G.); (L.G.); (J.B.)
| | | | - Thomas Backhaus
- Department of Biological and Environmental Sciences, University of Gothenburg, Carl Skottsbergs Gata 22B, 41319 Gothenburg, Sweden;
| | - Antonio Franco
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy; (S.S.); (A.F.)
| |
Collapse
|
27
|
Schoeters G, Verheyen VJ, Colles A, Remy S, Martin LR, Govarts E, Nelen V, Den Hond E, De Decker A, Franken C, Loots I, Coertjens D, Morrens B, Bastiaensen M, Gys C, Malarvannan G, Covaci A, Nawrot T, De Henauw S, Bellemans M, Leermakers M, Van Larebeke N, Baeyens W, Jacobs G, Voorspoels S, Nielsen F, Bruckers L. Internal exposure of Flemish teenagers to environmental pollutants: Results of the Flemish Environment and Health Study 2016-2020 (FLEHS IV). Int J Hyg Environ Health 2022; 242:113972. [PMID: 35453051 DOI: 10.1016/j.ijheh.2022.113972] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Revised: 04/07/2022] [Accepted: 04/09/2022] [Indexed: 12/12/2022]
Abstract
The Flemish Environment and Health Study (FLEHS) collects information on internal exposure to a broad range of environmental chemicals in the general population in Flanders, the Northern region of Belgium. The aim is to establish biomonitoring exposure distributions for the general population in support of public health and environmental policy, environmental risk assessment and risk management decisions. In 2017-2018, urine and blood samples were collected from 428 teenagers by a stratified clustered two stage randomized design. Samples were analyzed for a broad range of biomarkers related to exposure to chlorinated and newer pesticides, brominated and organophosphate flame retardants (BFR/OPFR), polychlorinated biphenyls (PCBs), bisphenols, phthalates and alternative plasticizers, per-and polyfluoroalkyl substances (PFAS), polycyclic aromatic hydrocarbons (PAHs), benzene, metals and trace elements. The geometric mean levels and percentiles of the distribution were estimated for each biomarker, for the whole study population and following stratification for sex, the household educational attainment and the residence area's urbanicity. Geometric means of biomarkers of lead, dichlorodiphenyltrichloroethane (DDT), PCBs, PAHs, regulated phthalates and bisphenol A (BPA) were lower than in the previous FLEHS cycles. Most biomarker levels were below health-based guidance values (HB-GVs). However, HB-GVs of urinary arsenic, blood lead, blood cadmium, sum of serum perfluorooctane sulfonate (PFOS) and perfluoro-1-hexanesulfonate (PFHxS) and the urinary pyrethroid metabolite (3-PBA) were exceeded in respectively 25%, 12%, 39.5%, 10% and 22% of the teenagers. These results suggest that the levels of exposure in the Flemish population to some environmental chemicals might be of concern. At the same time, we noticed that biomarkers for BPA substitutes, metabolites of OPFRs, an expanded list of PFAS, glyphosate and its metabolite could be measured in substantial proportions of participants. Interpretation of these levels in a health-risk context remains uncertain as HB-GVs are lacking. Household educational attainment and residential urbanicity were significant exposure determinants for many biomarkers and could influence specific biomarker levels up to 70% as shown by multiple regression analysis. The research consortium also took care of the broader external communication of results with participants, policy makers, professional groups and civil society organizations. Our study demonstrated that teenagers are exposed to a wide range of chemicals, it demonstrates the success of public policies to reduce exposure but also points to concern and further priorities and needs for follow up.
Collapse
Affiliation(s)
- G Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium.
| | - V J Verheyen
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - A Colles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - S Remy
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - L Rodriguez Martin
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - E Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - V Nelen
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - E Den Hond
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - A De Decker
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - C Franken
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - I Loots
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - D Coertjens
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - B Morrens
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - M Bastiaensen
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - C Gys
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - G Malarvannan
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - A Covaci
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - T Nawrot
- Centre for Environmental Sciences, Hasselt University, Agoralaan building D, 3590, Diepenbeek, Belgium
| | - S De Henauw
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium
| | - M Bellemans
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium
| | - M Leermakers
- Analytical, Environmental and Geo- Chemistry, Vrije Universiteit Brussel, Brussels, Belgium
| | - N Van Larebeke
- Analytical, Environmental and Geo- Chemistry, Vrije Universiteit Brussel, Brussels, Belgium
| | - W Baeyens
- Analytical, Environmental and Geo- Chemistry, Vrije Universiteit Brussel, Brussels, Belgium
| | - G Jacobs
- VITO GOAL, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - S Voorspoels
- VITO GOAL, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - F Nielsen
- Institute of Public Health, Department of Environmental Medicine, University of Southern Denmark, Odense, Denmark
| | - L Bruckers
- BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, 3500, Hasselt, Belgium
| |
Collapse
|
28
|
Harmon P, Otter R. A review of common non-ortho-phthalate plasticizers for use in food contact materials. Food Chem Toxicol 2022; 164:112984. [PMID: 35452769 DOI: 10.1016/j.fct.2022.112984] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2022] [Revised: 03/17/2022] [Accepted: 03/31/2022] [Indexed: 10/18/2022]
Abstract
Several non-ortho phthalate plasticizers, including ATBC, DEHA, DINCH, DOTP, and ESBO, are currently used in flexible PVC applications for food packaging and processing. The aim of this review is to summarize the available toxicity, migration, and human biomonitoring data. Available assessments from US CPSC, EFSA, other governmental and non-governmental organizations, and published toxicology studies were used to show that these plasticizers are generally well-studied and demonstrate low toxicity with a focus on potential carcinogenicity, reproductive, developmental, and endocrine related adverse effects as well as biodegradation, aquatic toxicity, and bioaccumulation. Seven other plasticizers, 2EHESBO, ASE, CMCHA, DBT, DEHCH, PETV, and TOTM, have at least some recent but limited food contact clearances; assessments from CPSC, EFSA, and robust summaries in the REACH dossiers were reviewed for these products. Data gaps were found for some of these products; however, there were no concerns raised by the existing data, and they for now have limited use in food contact applications. Migration of ASE, COMGHA, DINCH, DOTP, DEHCH, and TOTM in simulants for aqueous and low alcohol foods ranged from <0.02 to 0.165 mg/kg, which showed they are below established migration limits and well-suited for these applications. Human biomonitoring data are available for DINCH, DOTP, DEHA, DINA, and TOTM, and are essential for determining exposure from all uses.
Collapse
Affiliation(s)
- Patrick Harmon
- BASF Corporation, 11750 Katy Freeway, Houston, TX, 77079, United States.
| | - Rainer Otter
- BASF SE, Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, D-67056, Germany
| |
Collapse
|
29
|
Joksić AŠ, Tratnik JS, Mazej D, Kocman D, Stajnko A, Eržen I, Horvat M. Polycyclic aromatic hydrocarbons (PAHs) in men and lactating women in Slovenia: Results of the first national human biomonitoring. Int J Hyg Environ Health 2022; 241:113943. [DOI: 10.1016/j.ijheh.2022.113943] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 01/27/2022] [Accepted: 02/03/2022] [Indexed: 02/04/2023]
|
30
|
Environmental Contamination and Chronic Exposure to Endocrine-Disrupting Phthalates: An Overlooked and Emerging Determinant for Hormone-Sensitive Cancers. J Indian Inst Sci 2022. [DOI: 10.1007/s41745-022-00319-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
31
|
Proficiency and Interlaboratory Variability in the Determination of Phthalate and DINCH Biomarkers in Human Urine: Results from the HBM4EU Project. TOXICS 2022; 10:toxics10020057. [PMID: 35202244 PMCID: PMC8878211 DOI: 10.3390/toxics10020057] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 12/17/2021] [Accepted: 01/21/2022] [Indexed: 12/04/2022]
Abstract
A quality assurance/quality control program was implemented in the framework of the EU project HBM4EU to assess and improve the comparability of biomarker analysis and to build a network of competent laboratories. Four rounds of proficiency tests were organized for 15 phthalate and two DINCH urinary biomarkers (0.2–138 ng/mL) over a period of 18 months, with the involvement of 28 laboratories. A substantial improvement in performance was observed after the first round in particular, and by the end of the program, an average satisfactory performance rate of 90% was achieved. The interlaboratory reproducibility as derived from the participants’ results varied for the various biomarkers and rounds, with an average of 24% for the biomarkers of eight single-isomer phthalates (e.g., DnBP and DEHP) and 43% for the more challenging biomarkers of the mixed-isomer phthalates (DiNP, DiDP) and DINCH. When the reproducibility was based only on the laboratories that consistently achieved a satisfactory performance, this improved to 17% and 26%, respectively, clearly demonstrating the success of the QA/QC efforts. The program thus aided in building capacity and the establishment of a network of competent laboratories able to generate comparable and accurate HBM data for phthalate and DINCH biomarkers in 14 EU countries. In addition, global comparability was ensured by including external expert laboratories.
Collapse
|
32
|
Haverinen E, Fernandez MF, Mustieles V, Tolonen H. Metabolic Syndrome and Endocrine Disrupting Chemicals: An Overview of Exposure and Health Effects. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:13047. [PMID: 34948652 PMCID: PMC8701112 DOI: 10.3390/ijerph182413047] [Citation(s) in RCA: 46] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Revised: 12/08/2021] [Accepted: 12/09/2021] [Indexed: 12/15/2022]
Abstract
Increasing prevalence of metabolic syndrome (MetS) is causing a significant health burden among the European population. Current knowledge supports the notion that endocrine-disrupting chemicals (EDCs) interfere with human metabolism and hormonal balance, contributing to the conventionally recognized lifestyle-related MetS risk factors. This review aims to identify epidemiological studies focusing on the association between MetS or its individual components (e.g., obesity, insulin resistance, diabetes, dyslipidemia and hypertension) and eight HBM4EU priority substances (bisphenol A (BPA), per- and polyfluoroalkyl substances (PFASs), phthalates, polycyclic aromatic hydrocarbons (PAHs), pesticides and heavy metals (cadmium, arsenic and mercury)). Thus far, human biomonitoring (HBM) studies have presented evidence supporting the role of EDC exposures on the development of individual MetS components. The strength of the association varies between the components and EDCs. Current evidence on metabolic disturbances and EDCs is still limited and heterogeneous, and mainly represent studies from North America and Asia, highlighting the need for well-conducted and harmonized HBM programmes among the European population. Rigorous and ongoing HBM in combination with health monitoring can help to identify the most concerning EDC exposures, to guide future risk assessment and policy actions.
Collapse
Affiliation(s)
- Elsi Haverinen
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), 00300 Helsinki, Finland;
| | - Mariana F. Fernandez
- Department of Radiology, School of Medicine, University of Granada, 18016 Granada, Spain; (M.F.F.); (V.M.)
- Center of Biomedical Research (CIBM), University of Granada, 18016 Granada, Spain
- Consortium for Biomedical Research and Epidemiology & Public Health (CIBERESP), 28029 Madrid, Spain
| | - Vicente Mustieles
- Department of Radiology, School of Medicine, University of Granada, 18016 Granada, Spain; (M.F.F.); (V.M.)
- Center of Biomedical Research (CIBM), University of Granada, 18016 Granada, Spain
- Consortium for Biomedical Research and Epidemiology & Public Health (CIBERESP), 28029 Madrid, Spain
| | - Hanna Tolonen
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), 00300 Helsinki, Finland;
| |
Collapse
|
33
|
't Mannetje A, Coakley J, Douwes J. Levels and determinants of urinary phthalate metabolites in New Zealand children and adults. Int J Hyg Environ Health 2021; 238:113853. [PMID: 34634755 DOI: 10.1016/j.ijheh.2021.113853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2021] [Revised: 09/23/2021] [Accepted: 09/29/2021] [Indexed: 11/19/2022]
Abstract
BACKGROUND This first national biomonitoring survey of urinary phthalate metabolites in the New Zealand population aimed to provide baseline data, identify exposure determinants, and make comparisons with health-based exposure guidance values. METHODS The survey conducted in 2014-2016 involved the collection of morning-void urine from 298 children (5-18 years) and 302 adults (20-65 years), 33% of Māori ethnicity. A questionnaire collected information on demographic factors and diet. Urine was analysed for creatinine, specific gravity, and 10 phthalate metabolites through liquid chromatography tandem-mass spectrometry (MMP; MEP; MBP iso+n; MBzP; MCHP; MEHP; MEOHP; MEHHP; MCPP; and MiNP). Determinants of exposure were assessed using multivariable linear regression. RESULTS Detection frequencies exceeded 95% for metabolites of DEP, DEHP and DBP. The highest GM was observed for the DBP metabolite MBP iso+n (36.1 μg/L adults; 60.5 μg/L children), followed by the sum of three DEHP metabolites (MEHP+MEOHP+MEHHP: 19.0 μg/L adults; 37.0 μg/L children), and the DEP metabolite MEP (19.1 μg/L adults; 12.0 μg/L children). For most phthalate metabolites New Zealand levels were in the mid-range of internationally reported levels, while for DEP they were in the low range. Māori and non-Māori had similar levels. Children had higher GMs than adults for most metabolites, except for MEP. A proportion of children and adults exceeded the biomonitoring equivalents of health-based guidance values for DBP (0-16% and 0-3% respectively), and DEHP (0-0.7% and 0-0.3% respectively). Eating warm meals from plastic containers ≥2 times/week was associated with higher levels of DEHP metabolites, MBP iso+n, and MBzP. CONCLUSION Phthalate exposure is omnipresent in both children and adults in New Zealand. Exceedances of the biomonitoring equivalents for DBP and DEHP indicate that potential health effects from exposure to these phthalates cannot be excluded with sufficient certainty.
Collapse
Affiliation(s)
- Andrea 't Mannetje
- Research Centre for Hauora and Health, Massey University, Wellington, New Zealand.
| | - Jonathan Coakley
- Research Centre for Hauora and Health, Massey University, Wellington, New Zealand
| | - Jeroen Douwes
- Research Centre for Hauora and Health, Massey University, Wellington, New Zealand
| |
Collapse
|
34
|
The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) for the aprotic solvents N-methyl-2-pyrrolidone (NMP) and N-ethyl-2-pyrrolidone (NEP). Int J Hyg Environ Health 2021; 238:113856. [PMID: 34619432 PMCID: PMC8573589 DOI: 10.1016/j.ijheh.2021.113856] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Revised: 10/01/2021] [Accepted: 10/02/2021] [Indexed: 11/20/2022]
Abstract
Toxicologically and/or epidemiologically derived guidance values referring to the internal exposure of humans are a prerequisite for an easy to use health-based interpretation of human biomonitoring (HBM) results. The European Joint Programme HBM4EU derives such values, named human biomonitoring guidance values (HBM-GVs), for priority substances which could be of regulatory relevance for policy makers and have been identified by experts of the participating countries, ministries, agencies and stakeholders at EU and national level. NMP and NEP are such substances for which unresolved policy relevant issues should be clarified by targeted research. Since widespread exposure of the general population in Germany to NMP and NEP was shown for the age groups 3–17 years and 20–29 years, further investigations on exposure to NMP and NEP in other European countries are warranted. The HBM-GVs derived for both solvents focus on developmental toxicity as decisive endpoint. They amount for the sum of the two specific urinary NMP metabolites 5-HNMP and 2-HMSI and likewise of the two specific urinary NEP metabolites 5-HNEP and 2-HESI to 10 mg/L for children and 15 mg/L for adolescents/adults. The values were determined following a consultation process on the value proposals within HBM4EU. A health-based risk assessment was performed using the newly derived HBM-GVGenPop and exposure data from two recent studies from Germany. The risk assessment revealed that even when considering the combined exposure to both substances by applying the Hazard Index approach, the measured concentrations are below the HBM-GVGenPop in all cases investigated (i.e., children, adolescents and young adults). HBM-GVs are a prerequisite for an easy to use health-based risk assessment of human biomonitoring results. For NMP and NEP metabolites in urine, respectively, HBM-GVs were set for children and adolescents/adults. First HBM exposure data indicate widespread exposure of German children, adolescents and young adults to NMP and NEP. The Hazard Index approach revealed that even when combined exposure to both solvents is assessed, HBM-GVs are not exceeded.
Collapse
|
35
|
Lifestyle Habits and Exposure to BPA and Phthalates in Women of Childbearing Age from Northern Italy: A Pilot Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021; 18:ijerph18189710. [PMID: 34574636 PMCID: PMC8469822 DOI: 10.3390/ijerph18189710] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 09/03/2021] [Accepted: 09/10/2021] [Indexed: 12/15/2022]
Abstract
Background: Endocrine-disrupting chemicals (EDCs) are compounds that interfere with aspects of hormonal signaling. Considerable attention has been paid to their biological effects especially in women of childbearing age or during pregnancy as EDCs have been reported to cross the placenta becoming concentrated in the fetus' circulation. Lifestyle habits, daily consumption of packaged foods and use of healthcare/cosmetic products are associated with increased EDCs levels. This cross-sectional research examined the EDCs levels and the lifestyle determinants of EDC exposure in a cohort of reproductive-age women from Northern Italy. Methods: Forty-five women (median age: 36, IQR: 30-38) were evaluated for urinary bisphenol A (BPA) and phthalates levels and also studied for EDCs' major determinants of daily exposure; food frequency/dietary, physical activity, smoking habits and weight status. Results: Although 100% of women seemed to have been exposed to common sources of EDCs, they reported a healthy lifestyle. The multivariable model described a positive and significant association between consumption of sauces/dressings in plastic containers and monoethyl phthalate exposure (p = 0.037). Conclusions: Since reproductive age encompasses a critical window for future health and functioning of the "mothers-to-be" and their children, future studies on prenatal dietary BPA and phthalate exposure and the role of consumer product choices in reducing such exposure are recommended.
Collapse
|
36
|
Lemke N, Murawski A, Lange R, Weber T, Apel P, Dębiak M, Koch HM, Kolossa-Gehring M. Substitutes mimic the exposure behaviour of REACH regulated phthalates - A review of the German HBM system on the example of plasticizers. Int J Hyg Environ Health 2021; 236:113780. [PMID: 34126298 DOI: 10.1016/j.ijheh.2021.113780] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2021] [Revised: 04/30/2021] [Accepted: 05/27/2021] [Indexed: 12/19/2022]
Abstract
The population is constantly exposed to potentially harmful substances present in the environment, including inter alia food and drinking water, consumer products, and indoor air. Human biomonitoring (HBM) is a valuable tool to determine the integral, internal exposure of the general population, including vulnerable subgroups, to provide the basis for risk assessment and policy advice. The German HBM system comprises of five pillars: (1) the development of suitable analytical methods for new substances of concern, (2) cross-sectional population-representative German Environmental Surveys (GerES), (3) time trend analyses using archived samples from the Environmental Specimen Bank (ESB), (4) the derivation of health-based guidance values as a risk assessment tool, and (5) transfer of data into the European cooperation network HBM4EU. The goal of this paper is to present the complementary elements of the German HBM system and to show its strengths and limitations on the example of plasticizers. Plasticizers have been identified by EU services and HBM4EU partners as priority substances for chemical policy at EU level. Using the complementary elements of the German HBM system, the internal exposure to classical phthalates and novel alternative plasticizers can be reliably monitored. It is shown that market changes, due to regulation of certain phthalates and the rise of substitutes, are rapidly reflected in the internal exposure of the population. It was shown that exposure to DEHP, DiBP, DnBP, and BBzP decreased considerably, whereas exposure to the novel substitutes such as DPHP, DEHTP, and Hexamoll®DINCH has increased significantly. While health-based guidance values for several phthalates (esp. DnBP, DiBP, DEHP) were exceeded quite often at the turn of the millennium, exceedances today have become rarer. Still, also the latest GerES reveals the ubiquitous and concurrent exposures to many plasticizers. Of concern is that the youngest children showed the highest exposures to most of the investigated plasticizers and in some cases their levels of DiBP and DnBP still exceeded health-based guidance values. Over the last years, mixture exposures are increasingly recognized as relevant, especially if the toxicological modes of action are similar. This is supported by a cumulative risk assessment for four endocrine active phthalates which confirms the still concerning cumulative exposure in many young children. Given the adverse health effects of some phthalates and the limited toxicological knowledge of substitutes, exposure reduction and surveillance are needed on German and EU-level. Substitutes need to be monitored, to intervene if exposures are threatening to exceed acceptable levels, or if new toxicological data question their appropriateness. It is strongly recommended to reconsider the use of plastics and plasticizers.
Collapse
Affiliation(s)
- Nora Lemke
- German Environment Agency (UBA), Berlin, Germany
| | | | - Rosa Lange
- German Environment Agency (UBA), Berlin, Germany
| | - Till Weber
- German Environment Agency (UBA), Berlin, Germany
| | - Petra Apel
- German Environment Agency (UBA), Berlin, Germany
| | | | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-University Bochum, Germany
| | | |
Collapse
|